## SUSAN BLANEY

| | Title| Professor  
---|---  
Institution| Baylor College of Medicine  
Department| Department of Pediatrics  
Address| 1102 BATES  
Houston, TX 77030  
  
Email|
![](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/EmailHandler.ashx?msg=Jak84GvCOav3RYKj5X%2fX&rnd=e957e3db-a5dc-4393-a97d-4e17eef1124c)  
vCard| [Download
vCard](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/vcard.aspx?subject=268174)  
  
![](https://profiles.viictr.org/profile/Modules/CustomViewPersonGeneralInfo/PhotoHandler.ashx?NodeID=268174&cachekey=94a0d568-ffda-4e6c-9bd2-24003b4f87fa)  
  

  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Overview  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
overview

Susan M. Blaney, M.D. is the David G. Poplack, MD Chair in Pediatric Oncology
and The Elise C. Young Chair in Pediatrics Oncology. She is Professor in the
Department of Pediatrics at Baylor College of Medicine (BCM) where she serves
as the Division Chief in Pediatric Hematology-Oncology. She is also the
Director of Texas Children's Cancer and Hematology Center at Texas Children's
Hospital. She has extensive experience in clinical and translational research
with a focus on the development of new treatment strategies for children with
brain tumors and other refractory cancers. In the past, she served as the Vice
President for Clinical and Translational Research at BCM, Executive Vice Chair
of the Department of Pediatrics, Vice Chair for the Children’s Oncology Group,
an international clinical trial cooperative group supported by the National
Cancer Institute (NCI), and Chair of the NCI's Pediatric Phase 1 and Pilot
Consortium. She has served on the Clinical Trial Advisory Committee for the
National Cancer Institute and as a consultant of the FDA’s pediatric Oncology
Drug Advisory Committee.  

  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Bibliographic  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
selected publications

Publications listed below are automatically derived from MEDLINE/PubMed and
other sources, which might result in incorrect or missing publications.
Faculty can
[login](https://profiles.viictr.org/loginOptions.aspx?pin=send&method=login&edit=true)
to make corrections and additions.

Newest | Oldest | Most Cited | Most Discussed | Timeline | Field Summary | Plain Text

PMC Citations indicate the number of times the publication was cited by
articles in PubMed Central, and the Altmetric score represents citations in
news articles and social media. (Note that publications are often cited in
additional ways that are not shown here.) Fields are based on how the National
Library of Medicine (NLM) classifies the publication's journal and might not
represent the specific topic of the publication. Translation tags are based on
the publication type and the MeSH terms NLM assigns to the publication. Some
publications (especially newer ones and publications not in PubMed) might not
yet be assigned Field or Translation tags.) Click a Field or Translation tag
to filter the publications.

  1. Lin FY, Stuckert A, Tat C, White M, Ruggieri L, Zhang H, Mehta B, [Lapteva N](https://profiles.viictr.org/profile/269143), [Mei Z](https://profiles.viictr.org/profile/267093), Major A, Thakkar S, Shum T, Parikh K, Wu MF, Lindsay HB, [Scherer L](https://profiles.viictr.org/profile/22016570), Shekar M, [Baxter P](https://profiles.viictr.org/profile/265524), Wang T, [Grilley B](https://profiles.viictr.org/profile/266987), [Moeller K](https://profiles.viictr.org/profile/51898388), Hicks J, [Roy A](https://profiles.viictr.org/profile/268647), [Anastas J](https://profiles.viictr.org/profile/33092477), Malbari F, Aldave G, [Chintagumpala M](https://profiles.viictr.org/profile/268049), **Blaney S** , [Parsons DW](https://profiles.viictr.org/profile/265886), [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811), [Rooney CM](https://profiles.viictr.org/profile/268355), [Omer B](https://profiles.viictr.org/profile/3009902). Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors. J Clin Oncol. 2024 May 21; JCO2302019. PMID: [38771986](//www.ncbi.nlm.nih.gov/pubmed/38771986).

Citations:  Fields:

Neo Neoplasms

  2. [Su JM](https://profiles.viictr.org/profile/268196), Kilburn LB, Mansur DB, Krailo M, Buxton A, Adekunle A, Gajjar A, Adamson PC, Weigel B, Fox E, **Blaney SM** , Fouladi M. Phase I/II trial of vorinostat and radiation and maintenance vorinostat in children with diffuse intrinsic pontine glioma: A Children's Oncology Group report. Neuro Oncol. 2022 04 01; 24(4):655-664. PMID: [34347089](//www.ncbi.nlm.nih.gov/pubmed/34347089); PMCID: [PMC8972206](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8972206).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/34347089/citedby/) Fields:

Neo NeoplasmsNeu Neurology

Translation:HumansCTClinical Trials

  3. [Kamdar KY](https://profiles.viictr.org/profile/270282), Kim TO, [Doherty EE](https://profiles.viictr.org/profile/14348409), Pfeiffer TM, [Qasim SL](https://profiles.viictr.org/profile/14348410), Suell MN, Yates AM, **Blaney SM**. COVID-19 outcomes in a large pediatric hematology-oncology center in Houston, Texas. Pediatr Hematol Oncol. 2021 Nov; 38(8):695-706. PMID: [34032552](//www.ncbi.nlm.nih.gov/pubmed/34032552).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/34032552/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansPHPublic Health

  4. Arabzade A, Zhao Y, Varadharajan S, Chen HC, Jessa S, Rivas B, Stuckert AJ, Solis M, [Kardian A](https://profiles.viictr.org/profile/28999343), Tlais D, Golbourn BJ, Stanton AJ, Chan YS, Olson C, [Karlin KL](https://profiles.viictr.org/profile/1826677), Kong K, Kupp R, Hu B, Injac SG, Ngo M, Wang PR, Sahm F, Kawauchi D, Pfister SM, Lin CY, Hodges HC, Singh I, [Westbrook TF](https://profiles.viictr.org/profile/267742), [Chintagumpala MM](https://profiles.viictr.org/profile/268049), **Blaney SM** , [Parsons DW](https://profiles.viictr.org/profile/265886), Pajtler KW, Agnihotri S, Gilbertson RJ, [Yi J](https://profiles.viictr.org/profile/15317815), Jabado N, Kleinman CL, Bertrand KC, [Deneen B](https://profiles.viictr.org/profile/266334), Mack SC, De Le?n LA. ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma. Cancer Discov. 2021 09; 11(9):2200-2215. PMID: [33741710](//www.ncbi.nlm.nih.gov/pubmed/33741710); PMCID: [PMC8418998](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8418998).

Citations:
[18](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33741710/citedby/) Fields:

Neo Neoplasms

Translation:Animals

  5. [Foster JH](https://profiles.viictr.org/profile/1826370), Voss SD, Hall DC, [Minard CG](https://profiles.viictr.org/profile/267444), Balis FM, Wilner K, [Berg SL](https://profiles.viictr.org/profile/266981), Fox E, Adamson PC, **Blaney SM** , Weigel BJ, Moss? YP. Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912). Clin Cancer Res. 2021 07 01; 27(13):3543-3548. PMID: [33568345](//www.ncbi.nlm.nih.gov/pubmed/33568345); PMCID: [PMC8254744](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8254744).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33568345/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  6. Greengard E, Mosse YP, Liu X, [Minard CG](https://profiles.viictr.org/profile/267444), Reid JM, Voss S, Wilner K, Fox E, Balis F, **Blaney SM** , Adamson PC, Weigel BJ. Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children's Oncology Group phase 1 consortium study (ADVL1212). Cancer Chemother Pharmacol. 2020 12; 86(6):829-840. PMID: [33095287](//www.ncbi.nlm.nih.gov/pubmed/33095287); PMCID: [PMC7757912](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7757912).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33095287/citedby/) Fields:

Ant Antineoplastic AgentsNeo Neoplasms

Translation:HumansCTClinical Trials

  7. [Baxter PA](https://profiles.viictr.org/profile/265524), [Su JM](https://profiles.viictr.org/profile/268196), Onar-Thomas A, Billups CA, Li XN, Poussaint TY, Smith ER, Thompson P, [Adesina A](https://profiles.viictr.org/profile/268657), Ansell P, Giranda V, [Paulino A](https://profiles.viictr.org/profile/12583636), Kilburn L, Quaddoumi I, Broniscer A, **Blaney SM** , Dunkel IJ, Fouladi M. A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study. Neuro Oncol. 2020 06 09; 22(6):875-885. PMID: [32009149](//www.ncbi.nlm.nih.gov/pubmed/32009149); PMCID: [PMC7283021](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7283021).

Citations:
[21](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32009149/citedby/) Fields:

Neo NeoplasmsNeu Neurology

Translation:HumansCTClinical Trials

  8. [Su JM](https://profiles.viictr.org/profile/268196), Murray JC, McNall-Knapp RY, Bowers DC, Shah S, [Adesina AM](https://profiles.viictr.org/profile/268657), [Paulino AC](https://profiles.viictr.org/profile/12583636), Jo E, Mo Q, [Baxter PA](https://profiles.viictr.org/profile/265524), **Blaney SM**. A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma. Pediatr Blood Cancer. 2020 06; 67(6):e28283. PMID: [32285998](//www.ncbi.nlm.nih.gov/pubmed/32285998).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32285998/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCTClinical Trials

  9. [Schafer ES](https://profiles.viictr.org/profile/270055), [Rau RE](https://profiles.viictr.org/profile/270060), [Berg SL](https://profiles.viictr.org/profile/266981), Liu X, [Minard CG](https://profiles.viictr.org/profile/267444), Bishop AJR, Romero JC, Hicks MJ, Nelson MD, Voss S, Reid JM, Fox E, Weigel BJ, **Blaney SM**. Phase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children's Oncology Group Phase 1 Consortium study (ADVL1411). Pediatr Blood Cancer. 2020 02; 67(2):e28073. PMID: [31724813](//www.ncbi.nlm.nih.gov/pubmed/31724813); PMCID: [PMC9134216](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9134216).

Citations:
[13](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31724813/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCTClinical Trials

  10. Fox E, Teachey DT, Reid JM, Safgren SL, Carol H, Lock RB, Houghton PJ, Smith MA, Hall D, Barkauskas DA, Krailo M, Voss SD, [Berg SL](https://profiles.viictr.org/profile/266981), **Blaney SM** , Weigel BJ, Moss? YP. A Phase II Study of Alisertib in Children with Recurrent/Refractory Solid Tumors or Leukemia: Children's Oncology Group Phase I and Pilot Consortium (ADVL0921). Clin Cancer Res. 2019 06 01; 25(11):3229-3238. PMID: [30777875](//www.ncbi.nlm.nih.gov/pubmed/30777875); PMCID: [PMC6897379](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6897379).

Citations:
[25](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30777875/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCTClinical Trials

  11. **Blaney SM**. Editorial: Recent advances in pediatric oncology. Curr Opin Pediatr. 2019 02; 31(1):1-2. PMID: [30614919](//www.ncbi.nlm.nih.gov/pubmed/30614919).

Citations:  Fields:

Ped Pediatrics

Translation:Humans

  12. Bertagnolli MM, **Blaney SM** , Blanke CD, Dancey J, Mannel RS, O'Dwyer PJ, Schnall MD, Wolmark N, Coalition of Cancer Cooperative Groups, Curran WJ. Current Activities of the Coalition of Cancer Cooperative Groups. J Natl Cancer Inst. 2019 01 01; 111(1):11-18. PMID: [30544145](//www.ncbi.nlm.nih.gov/pubmed/30544145); PMCID: [PMC6657272](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6657272).

Citations:  Fields:

Neo Neoplasms

Translation:Humans

  13. Cole PD, McCarten KM, Pei Q, Spira M, Metzger ML, Drachtman RA, [Horton TM](https://profiles.viictr.org/profile/266755), Bush R, **Blaney SM** , Weigel BJ, Kelly KM. Brentuximab vedotin with gemcitabine for paediatric and young adult patients with relapsed or refractory Hodgkin's lymphoma (AHOD1221): a Children's Oncology Group, multicentre single-arm, phase 1-2 trial. Lancet Oncol. 2018 09; 19(9):1229-1238. PMID: [30122620](//www.ncbi.nlm.nih.gov/pubmed/30122620); PMCID: [PMC6487196](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6487196).

Citations:
[18](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30122620/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  14. [Schafer ES](https://profiles.viictr.org/profile/270055), [Rau RE](https://profiles.viictr.org/profile/270060), [Berg S](https://profiles.viictr.org/profile/266981), Liu X, [Minard CG](https://profiles.viictr.org/profile/267444), D'Adamo D, Scott R, Reyderman L, Martinez G, Devarajan S, Reid JM, Fox E, Weigel BJ, **Blaney SM**. A phase 1 study of eribulin mesylate (E7389), a novel microtubule-targeting chemotherapeutic agent, in children with refractory or recurrent solid tumors: A Children's Oncology Group Phase 1 Consortium study (ADVL1314). Pediatr Blood Cancer. 2018 08; 65(8):e27066. PMID: [29719113](//www.ncbi.nlm.nih.gov/pubmed/29719113); PMCID: [PMC6019176](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6019176).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29719113/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCellsCTClinical Trials

  15. Chuk MK, Widemann BC, [Minard CG](https://profiles.viictr.org/profile/267444), Liu X, Kim A, Bernhardt MB, Kudgus RA, Reid JM, Voss SD, **Blaney S** , Fox E, Weigel BJ. A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group. Pediatr Blood Cancer. 2018 08; 65(8):e27077. PMID: [29693796](//www.ncbi.nlm.nih.gov/pubmed/29693796); PMCID: [PMC6082380](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6082380).

Citations:
[12](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29693796/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCTClinical Trials

  16. **Blaney SM**. Recent advances in pediatric oncology. Curr Opin Pediatr. 2018 02; 30(1):1-2. PMID: [29176358](//www.ncbi.nlm.nih.gov/pubmed/29176358).

Citations:  Fields:

Ped Pediatrics

Translation:Humans

  17. [Rau RE](https://profiles.viictr.org/profile/270060), [Dreyer Z](https://profiles.viictr.org/profile/269653), Choi MR, Liang W, Skowronski R, Allamneni KP, Devidas M, Raetz EA, Adamson PC, **Blaney SM** , Loh ML, Hunger SP. Outcome of pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated Erwinia asparaginase, pegcrisantaspase: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2018 03; 65(3). PMID: [29090524](//www.ncbi.nlm.nih.gov/pubmed/29090524); PMCID: [PMC5839116](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5839116).

Citations:
[17](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29090524/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCellsCTClinical Trials

  18. Kilburn LB, Kocak M, [Baxter P](https://profiles.viictr.org/profile/265524), Poussaint TY, [Paulino AC](https://profiles.viictr.org/profile/12583636), McIntyre C, Lemenuel-Diot A, Lopez-Diaz C, Kun L, [Chintagumpala M](https://profiles.viictr.org/profile/268049), [Su JM](https://profiles.viictr.org/profile/268196), Broniscer A, Baker JN, Hwang EI, Fouladi M, Boyett JM, **Blaney SM**. A pediatric brain tumor consortium phase II trial of capecitabine rapidly disintegrating tablets with concomitant radiation therapy in children with newly diagnosed diffuse intrinsic pontine gliomas. Pediatr Blood Cancer. 2018 Feb; 65(2). PMID: [29090526](//www.ncbi.nlm.nih.gov/pubmed/29090526); PMCID: [PMC5774861](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5774861).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29090526/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCTClinical Trials

  19. Moss? YP, Voss SD, Lim MS, Rolland D, [Minard CG](https://profiles.viictr.org/profile/267444), Fox E, Adamson P, Wilner K, **Blaney SM** , Weigel BJ. Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study. J Clin Oncol. 2017 Oct 01; 35(28):3215-3221. PMID: [28787259](//www.ncbi.nlm.nih.gov/pubmed/28787259); PMCID: [PMC5617123](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5617123).

Citations:
[92](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28787259/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  20. Leary SES, Park JR, Reid JM, Ralya AT, Baruchel S, Wu B, Roberts TPL, Liu X, [Minard CG](https://profiles.viictr.org/profile/267444), Fox E, Weigel B, **Blaney S**. Pediatric Phase I Trial and Pharmacokinetic Study of Trebananib in Relapsed Solid Tumors, Including Primary Tumors of the Central Nervous System ADVL1115: A Children's Oncology Group Phase I Consortium Report. Clin Cancer Res. 2017 Oct 15; 23(20):6062-6069. PMID: [28751444](//www.ncbi.nlm.nih.gov/pubmed/28751444); PMCID: [PMC5641249](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5641249).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28751444/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  21. Geller JI, Perentesis JP, Liu X, [Minard CG](https://profiles.viictr.org/profile/267444), Kudgus RA, Reid JM, Fox E, **Blaney SM** , Weigel BJ. A phase 1 study of the c-Met inhibitor, tivantinib (ARQ197) in children with relapsed or refractory solid tumors: A Children's Oncology Group study phase 1 and pilot consortium trial (ADVL1111). Pediatr Blood Cancer. 2017 Nov; 64(11). PMID: [28449393](//www.ncbi.nlm.nih.gov/pubmed/28449393); PMCID: [PMC5657151](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5657151).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28449393/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCTClinical Trials

  22. Rheingold SR, Tasian SK, Whitlock JA, Teachey DT, Borowitz MJ, Liu X, [Minard CG](https://profiles.viictr.org/profile/267444), Fox E, Weigel BJ, **Blaney SM**. A phase 1 trial of temsirolimus and intensive re-induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukaemia: a Children's Oncology Group study (ADVL1114). Br J Haematol. 2017 05; 177(3):467-474. PMID: [28295182](//www.ncbi.nlm.nih.gov/pubmed/28295182); PMCID: [PMC5403576](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5403576).

Citations:
[12](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28295182/citedby/) Fields:

Hem Hematology

Translation:HumansCTClinical Trials

  23. Heikamp EB, **Blaney SM**. 50 Years Ago in The Journal of Pediatrics: Diencephalic Syndromes of Infancy: Report of 3 Children with Emaciation Syndrome and Disproportionately Large Hands and Feet. J Pediatr. 2017 03; 182:113. PMID: [28237444](//www.ncbi.nlm.nih.gov/pubmed/28237444).

Citations:  Fields:

Ped Pediatrics

Translation:Humans

  24. Balis FM, Thompson PA, Mosse YP, **Blaney SM** , [Minard CG](https://profiles.viictr.org/profile/267444), Weigel BJ, Fox E. First-dose and steady-state pharmacokinetics of orally administered crizotinib in children with solid tumors: a report on ADVL0912 from the Children's Oncology Group Phase 1/Pilot Consortium. Cancer Chemother Pharmacol. 2017 Jan; 79(1):181-187. PMID: [28032129](//www.ncbi.nlm.nih.gov/pubmed/28032129); PMCID: [PMC5225209](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5225209).

Citations:
[13](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28032129/citedby/) Fields:

Ant Antineoplastic AgentsNeo Neoplasms

Translation:HumansCTClinical Trials

  25. Lagmay JP, Krailo MD, Dang H, Kim A, Hawkins DS, Beaty O, Widemann BC, Zwerdling T, [Bomgaars L](https://profiles.viictr.org/profile/266256), Langevin AM, Grier HE, Weigel B, **Blaney SM** , Gorlick R, Janeway KA. Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward. J Clin Oncol. 2016 09 01; 34(25):3031-8. PMID: [27400942](//www.ncbi.nlm.nih.gov/pubmed/27400942); PMCID: [PMC5012712](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5012712).

Citations:
[64](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27400942/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  26. **Blaney SM** , Adamson PC, Wechsler DS. The 2016 ASPHO Distinguished Career Award Goes to David G. Poplack, MD. Pediatr Blood Cancer. 2016 Jun; 63 Suppl 1:S5-6. PMID: [27077669](//www.ncbi.nlm.nih.gov/pubmed/27077669).

Citations:  Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

  27. Wetmore C, Daryani VM, Billups CA, Boyett JM, Leary S, Tanos R, Goldsmith KC, Stewart CF, **Blaney SM** , Gajjar A. Phase II evaluation of sunitinib in the treatment of recurrent or refractory high-grade glioma or ependymoma in children: a children's Oncology Group Study ACNS1021. Cancer Med. 2016 07; 5(7):1416-24. PMID: [27109549](//www.ncbi.nlm.nih.gov/pubmed/27109549); PMCID: [PMC4944867](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4944867).

Citations:
[27](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27109549/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  28. Loh ML, Tasian SK, [Rabin KR](https://profiles.viictr.org/profile/265501), Brown P, Magoon D, Reid JM, Chen X, Ahern CH, Weigel BJ, **Blaney SM**. A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 consortium study (ADVL1011). Pediatr Blood Cancer. 2015 Oct; 62(10):1717-24. PMID: [25976292](//www.ncbi.nlm.nih.gov/pubmed/25976292); PMCID: [PMC4546537](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4546537).

Citations:
[43](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25976292/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCTClinical Trials

  29. Hoffman LM, Fouladi M, Olson J, Daryani VM, Stewart CF, Wetmore C, Kocak M, Onar-Thomas A, Wagner L, Gururangan S, Packer RJ, **Blaney SM** , Gajjar A, Kun LE, Boyett JM, Gilbertson RJ. Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study. Childs Nerv Syst. 2015 Aug; 31(8):1283-9. PMID: [25930724](//www.ncbi.nlm.nih.gov/pubmed/25930724); PMCID: [PMC4681692](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4681692).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25930724/citedby/) Fields:

Neu NeurologyPed Pediatrics

Translation:HumansCTClinical Trials

  30. Kim A, Widemann BC, Krailo M, Jayaprakash N, Fox E, Weigel B, **Blaney SM**. Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2015 Sep; 62(9):1562-6. PMID: [26207356](//www.ncbi.nlm.nih.gov/pubmed/26207356); PMCID: [PMC4515771](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4515771).

Citations:
[24](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26207356/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCTClinical Trials

  31. Kolb EA, Sampson V, Stabley D, Walter A, Sol-Church K, Cripe T, Hingorani P, Ahern CH, Weigel BJ, Zwiebel J, **Blaney SM**. A phase I trial and viral clearance study of reovirus (Reolysin) in children with relapsed or refractory extra-cranial solid tumors: a Children's Oncology Group Phase I Consortium report. Pediatr Blood Cancer. 2015 May; 62(5):751-8. PMID: [25728527](//www.ncbi.nlm.nih.gov/pubmed/25728527); PMCID: [PMC4376570](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4376570).

Citations:
[25](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25728527/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCellsCTClinical Trials

  32. Fouladi M, Perentesis JP, Wagner LM, Vinks AA, Reid JM, Ahern C, Thomas G, Mercer CA, Krueger DA, Houghton PJ, Doyle LA, Chen H, Weigel B, **Blaney SM**. A Phase I Study of Cixutumumab (IMC-A12) in Combination with Temsirolimus (CCI-779) in Children with Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Report. Clin Cancer Res. 2015 Apr 01; 21(7):1558-65. PMID: [25467181](//www.ncbi.nlm.nih.gov/pubmed/25467181); PMCID: [PMC4454739](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4454739).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25467181/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  33. Wagner LM, Fouladi M, Ahmed A, Krailo MD, Weigel B, DuBois SG, Doyle LA, Chen H, **Blaney SM**. Phase II study of cixutumumab in combination with temsirolimus in pediatric patients and young adults with recurrent or refractory sarcoma: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2015 Mar; 62(3):440-4. PMID: [25446280](//www.ncbi.nlm.nih.gov/pubmed/25446280); PMCID: [PMC4501773](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4501773).

Citations:
[55](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25446280/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCTClinical Trials

  34. Kilburn LB, Kocak M, Decker RL, Wetmore C, [Chintagumpala M](https://profiles.viictr.org/profile/268049), [Su J](https://profiles.viictr.org/profile/268196), Goldman S, Banerjee A, Gilbertson R, Fouladi M, Kun L, Boyett JM, **Blaney SM**. A phase 1 and pharmacokinetic study of enzastaurin in pediatric patients with refractory primary central nervous system tumors: a pediatric brain tumor consortium study. Neuro Oncol. 2015 Feb; 17(2):303-11. PMID: [25431212](//www.ncbi.nlm.nih.gov/pubmed/25431212); PMCID: [PMC4288513](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4288513).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25431212/citedby/) Fields:

Neo NeoplasmsNeu Neurology

Translation:HumansCellsCTClinical Trials

  35. Burke MJ, Ahern C, Weigel BJ, Poirier JT, Rudin CM, Chen Y, Cripe TP, Bernhardt MB, **Blaney SM**. Phase I trial of Seneca Valley Virus (NTX-010) in children with relapsed/refractory solid tumors: a report of the Children's Oncology Group. Pediatr Blood Cancer. 2015 May; 62(5):743-50. PMID: [25307519](//www.ncbi.nlm.nih.gov/pubmed/25307519); PMCID: [PMC4376652](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4376652).

Citations:
[30](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25307519/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCellsCTClinical Trials

  36. Voss SD, Glade-Bender J, Spunt SL, DuBois SG, Widemann BC, Park JR, Leary SE, Nelson MD, Adamson PC, **Blaney SM** , Weigel B. Growth plate abnormalities in pediatric cancer patients undergoing phase 1 anti-angiogenic therapy: a report from the Children's Oncology Group Phase I Consortium. Pediatr Blood Cancer. 2015 Jan; 62(1):45-51. PMID: [25257751](//www.ncbi.nlm.nih.gov/pubmed/25257751); PMCID: [PMC4237627](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4237627).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25257751/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCTClinical Trials

  37. Su JM, Thompson P, [Adesina A](https://profiles.viictr.org/profile/268657), Li XN, Kilburn L, Onar-Thomas A, Kocak M, Chyla B, McKeegan E, Warren KE, Goldman S, Pollack IF, Fouladi M, Chen A, Giranda V, Boyett J, Kun L, **Blaney SM**. A phase I trial of veliparib (ABT-888) and temozolomide in children with recurrent CNS tumors: a pediatric brain tumor consortium report. Neuro Oncol. 2014 Dec; 16(12):1661-8. PMID: [24908656](//www.ncbi.nlm.nih.gov/pubmed/24908656); PMCID: [PMC4232081](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4232081).

Citations:
[34](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24908656/citedby/) Fields:

Neo NeoplasmsNeu Neurology

Translation:HumansCellsCTClinical Trials

  38. Widemann BC, Babovic-Vuksanovic D, Dombi E, Wolters PL, Goldman S, Martin S, Goodwin A, Goodspeed W, Kieran MW, Cohen B, **Blaney SM** , King A, Solomon J, Patronas N, Balis FM, Fox E, Steinberg SM, Packer RJ. Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas. Pediatr Blood Cancer. 2014 Sep; 61(9):1598-602. PMID: [24753394](//www.ncbi.nlm.nih.gov/pubmed/24753394); PMCID: [PMC7681788](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7681788).

Citations:
[42](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24753394/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCTClinical Trials

  39. Fouladi M, Perentesis JP, Phillips CL, Leary S, Reid JM, McGovern RM, Ingle AM, Ahern CH, Ames MM, Houghton P, Doyle LA, Weigel B, **BLANEY S** M. A phase I trial of MK-2206 in children with refractory malignancies: A Children's Oncology Group study. 2014; 61(7):1246-1251.

  40. Bagatell R, Norris R, Ingle AM, Ahern C, Voss S, Fox E, Little AR, Weigel BJ, Adamson PC, **BLANEY S**. Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: a Children's Oncology Group Study. 2014; 61(5):833-839.

  41. Thompson PA, Drissi R, Muscal JA, Panditharatna E, Fouladi M, Ingle AM, Ahern CH, Reid JM, Lin T, Weigel BJ, **Blaney SM**. A phase I trial of imetelstat in children with refractory or recurrent solid tumors: a Children's Oncology Group Phase I Consortium Study (ADVL1112). Clin Cancer Res. 2013 Dec 01; 19(23):6578-84. PMID: [24097866](//www.ncbi.nlm.nih.gov/pubmed/24097866); PMCID: [PMC4079262](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4079262).

Citations:
[23](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24097866/citedby/) Fields:

Neo Neoplasms

Translation:HumansCellsCTClinical Trials

  42. Weigel B, Malempati S, Reid JM, Voss SD, Cho SY, Chen HX, Krailo M, Villaluna D, Adamson PC, **Blaney SM**. Phase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2014 Mar; 61(3):452-6. PMID: [23956055](//www.ncbi.nlm.nih.gov/pubmed/23956055); PMCID: [PMC4511811](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4511811).

Citations:
[57](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23956055/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCTClinical Trials

  43. Glade Bender JL, Lee A, Reid JM, Baruchel S, Roberts T, Voss SD, Wu B, Ahern CH, Ingle AM, Harris P, Weigel BJ, **Blaney SM**. Phase I pharmacokinetic and pharmacodynamic study of pazopanib in children with soft tissue sarcoma and other refractory solid tumors: a children's oncology group phase I consortium report. J Clin Oncol. 2013 Aug 20; 31(24):3034-43. PMID: [23857966](//www.ncbi.nlm.nih.gov/pubmed/23857966); PMCID: [PMC3739862](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3739862).

Citations:
[56](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23857966/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  44. Fouladi M, Stewart CF, **Blaney SM** , Onar-Thomas A, Schaiquevich P, Packer RJ, Goldman S, Geyer JR, Gajjar A, Kun LE, Boyett JM, Gilbertson RJ. A molecular biology and phase II trial of lapatinib in children with refractory CNS malignancies: a pediatric brain tumor consortium study. J Neurooncol. 2013 Sep; 114(2):173-9. PMID: [23836190](//www.ncbi.nlm.nih.gov/pubmed/23836190); PMCID: [PMC4246636](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4246636).

Citations:
[27](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23836190/citedby/) Fields:

Neo NeoplasmsNeu Neurology

Translation:HumansCTClinical Trials

  45. Liu Z, Zhao X, Mao H, [Baxter PA](https://profiles.viictr.org/profile/265524), Huang Y, Yu L, [Wadhwa L](https://profiles.viictr.org/profile/267141), Su JM, [Adesina A](https://profiles.viictr.org/profile/268657), Perlaky L, Hurwitz M, Idamakanti N, Police SR, Hallenbeck PL, [Hurwitz RL](https://profiles.viictr.org/profile/266847), Lau CC, [Chintagumpala M](https://profiles.viictr.org/profile/268049), **Blaney SM** , Li XN. Intravenous injection of oncolytic picornavirus SVV-001 prolongs animal survival in a panel of primary tumor-based orthotopic xenograft mouse models of pediatric glioma. Neuro Oncol. 2013 Sep; 15(9):1173-85. PMID: [23658322](//www.ncbi.nlm.nih.gov/pubmed/23658322); PMCID: [PMC3748915](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3748915).

Citations:
[41](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23658322/citedby/) Fields:

Neo NeoplasmsNeu Neurology

Translation:AnimalsCells

  46. Kilburn LB, Kocak M, Schaedeli Stark F, Meneses-Lorente G, Brownstein C, Hussain S, [Chintagumpala M](https://profiles.viictr.org/profile/268049), Thompson PA, Gururangan S, Banerjee A, [Paulino AC](https://profiles.viictr.org/profile/12583636), Kun L, Boyett JM, **Blaney SM**. Phase I trial of capecitabine rapidly disintegrating tablets and concomitant radiation therapy in children with newly diagnosed brainstem gliomas and high-grade gliomas. Neuro Oncol. 2013 Jun; 15(6):759-66. PMID: [23592571](//www.ncbi.nlm.nih.gov/pubmed/23592571); PMCID: [PMC3661085](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3661085).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23592571/citedby/) Fields:

Neo NeoplasmsNeu Neurology

Translation:HumansCTClinical Trials

  47. Lim MS, Voss SD, Wilner K, Ruffner K, Laliberte J, Rolland D, Balis FM, Maris JM, Weigel BJ, Ingle AM, Ahern C, Adamson PC, **Blaney SM** , Moss? YP. Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study. Lancet Oncol. 2013 May; 14(6):472-80. PMID: [23598171](//www.ncbi.nlm.nih.gov/pubmed/23598171); PMCID: [PMC3730818](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3730818).

Citations:
[255](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23598171/citedby/)
Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  48. Hummel TR, Wagner L, Ahern C, Fouladi M, Reid JM, McGovern RM, Ames MM, Gilbertson RJ, [Horton T](https://profiles.viictr.org/profile/266755), Ingle AM, Weigel B, **Blaney SM**. A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: a Children's Oncology Group phase 1 consortium study. Pediatr Blood Cancer. 2013 Sep; 60(9):1452-7. PMID: [23554030](//www.ncbi.nlm.nih.gov/pubmed/23554030); PMCID: [PMC4139006](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4139006).

Citations:
[37](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23554030/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCellsCTClinical Trials

  49. **Blaney SM** , Tagen M, Onar-Thomas A, [Berg SL](https://profiles.viictr.org/profile/266981), Gururangan S, Scorsone K, [Su J](https://profiles.viictr.org/profile/268196), Goldman S, Kieran MW, Kun L, Boyett J, Stewart C. A phase-1 pharmacokinetic optimal dosing study of intraventricular topotecan for children with neoplastic meningitis: a Pediatric Brain Tumor Consortium study. Pediatr Blood Cancer. 2013 Apr; 60(4):627-32. PMID: [23002039](//www.ncbi.nlm.nih.gov/pubmed/23002039); PMCID: [PMC3573253](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3573253).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23002039/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCTClinical Trials

  50. Lipsitz E, Fox E, Teachey DT, Maris JM, Weigel B, Adamson PC, Ingle MA, Ahern CH, **Blaney SM** , Moss? YP. Pediatric phase I trial and pharmacokinetic study of MLN8237, an investigational oral selective small-molecule inhibitor of Aurora kinase A: a Children's Oncology Group Phase I Consortium study. Clin Cancer Res. 2012 Nov 01; 18(21):6058-64. PMID: [22988055](//www.ncbi.nlm.nih.gov/pubmed/22988055); PMCID: [PMC4008248](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4008248).

Citations:
[51](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22988055/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  51. Widemann BC, Kim A, Fox E, Baruchel S, Adamson PC, Ingle AM, Glade Bender J, Burke M, Weigel B, Stempak D, Balis FM, **Blaney SM**. A phase I trial and pharmacokinetic study of sorafenib in children with refractory solid tumors or leukemias: a Children's Oncology Group Phase I Consortium report. Clin Cancer Res. 2012 Nov 01; 18(21):6011-22. PMID: [22962440](//www.ncbi.nlm.nih.gov/pubmed/22962440); PMCID: [PMC4008314](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4008314).

Citations:
[52](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22962440/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  52. Muscal JA, Thompson PA, [Horton TM](https://profiles.viictr.org/profile/266755), Ingle AM, Ahern CH, McGovern RM, Reid JM, Ames MM, Espinoza-Delgado I, Weigel BJ, **Blaney SM**. A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: a Children's Oncology Group phase I consortium study (ADVL0916). Pediatr Blood Cancer. 2013 Mar; 60(3):390-5. PMID: [22887890](//www.ncbi.nlm.nih.gov/pubmed/22887890); PMCID: [PMC3511610](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3511610).

Citations:
[40](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22887890/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCTClinical Trials

  53. **Blaney SM** , Kocak M, Gajjar A, [Chintagumpala M](https://profiles.viictr.org/profile/268049), Merchant T, Kieran M, Pollack IF, Gururangan S, Geyer R, Phillips P, McLendon RE, Packer R, Goldman S, Banerjee A, Heideman R, Boyett JM, Kun L. Pilot study of systemic and intrathecal mafosfamide followed by conformal radiation for infants with intracranial central nervous system tumors: a pediatric brain tumor consortium study (PBTC-001). J Neurooncol. 2012 Sep; 109(3):565-71. PMID: [22790443](//www.ncbi.nlm.nih.gov/pubmed/22790443); PMCID: [PMC3529096](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3529096).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22790443/citedby/) Fields:

Neo NeoplasmsNeu Neurology

Translation:HumansCTClinical Trials

  54. Glade Bender J, **Blaney SM** , Borinstein S, Reid JM, Baruchel S, Ahern C, Ingle AM, Yamashiro DJ, Chen A, Weigel B, Adamson PC, Park JR. A phase I trial and pharmacokinetic study of aflibercept (VEGF Trap) in children with refractory solid tumors: a children's oncology group phase I consortium report. Clin Cancer Res. 2012 Sep 15; 18(18):5081-9. PMID: [22791883](//www.ncbi.nlm.nih.gov/pubmed/22791883); PMCID: [PMC3445751](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3445751).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22791883/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  55. Warwick AB, Malempati S, Krailo M, Melemed A, Gorlick R, Ames MM, Safgren SL, Adamson PC, **Blaney SM**. Phase 2 trial of pemetrexed in children and adolescents with refractory solid tumors: a Children's Oncology Group study. Pediatr Blood Cancer. 2013 Feb; 60(2):237-41. PMID: [22745043](//www.ncbi.nlm.nih.gov/pubmed/22745043); PMCID: [PMC3463652](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3463652).

Citations:
[16](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22745043/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCTClinical Trials

  56. Day ES, Zhang L, Thompson PA, Zawaski JA, Kaffes CC, [Gaber MW](https://profiles.viictr.org/profile/269276), **Blaney SM** , West JL. Vascular-targeted photothermal therapy of an orthotopic murine glioma model. Nanomedicine (Lond). 2012 Aug; 7(8):1133-48. PMID: [22583571](//www.ncbi.nlm.nih.gov/pubmed/22583571); PMCID: [PMC5375028](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5375028).

Citations:
[29](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22583571/citedby/) Fields:

Nan Nanotechnology

Translation:HumansAnimalsCells

  57. Malempati S, Weigel B, Ingle AM, Ahern CH, Carroll JM, Roberts CT, Reid JM, Schmechel S, Voss SD, Cho SY, Chen HX, Krailo MD, Adamson PC, **Blaney SM**. Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology Group. J Clin Oncol. 2012 Jan 20; 30(3):256-62. PMID: [22184397](//www.ncbi.nlm.nih.gov/pubmed/22184397); PMCID: [PMC3269952](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3269952).

Citations:
[91](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22184397/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  58. DuBois SG, Shusterman S, Reid JM, Ingle AM, Ahern CH, Baruchel S, Glade-Bender J, Ivy P, Adamson PC, **Blaney SM**. Tolerability and pharmacokinetic profile of a sunitinib powder formulation in pediatric patients with refractory solid tumors: a Children's Oncology Group study. Cancer Chemother Pharmacol. 2012 Apr; 69(4):1021-7. PMID: [22179104](//www.ncbi.nlm.nih.gov/pubmed/22179104); PMCID: [PMC4008320](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4008320).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22179104/citedby/) Fields:

Ant Antineoplastic AgentsNeo Neoplasms

Translation:HumansCTClinical Trials

  59. Baruchel S, Pappo A, Krailo M, Baker KS, Wu B, Villaluna D, Lee-Scott M, Adamson PC, **Blaney SM**. A phase 2 trial of trabectedin in children with recurrent rhabdomyosarcoma, Ewing sarcoma and non-rhabdomyosarcoma soft tissue sarcomas: a report from the Children's Oncology Group. Eur J Cancer. 2012 Mar; 48(4):579-85. PMID: [22088484](//www.ncbi.nlm.nih.gov/pubmed/22088484).

Citations:
[40](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22088484/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  60. Potter SL, [Berg S](https://profiles.viictr.org/profile/266981), Ingle AM, Krailo M, Adamson PC, **Blaney SM**. Phase 2 clinical trial of intrathecal topotecan in children with refractory leptomeningeal leukemia: a Children's Oncology Group trial (P9962). Pediatr Blood Cancer. 2012 Mar; 58(3):362-5. PMID: [21910214](//www.ncbi.nlm.nih.gov/pubmed/21910214); PMCID: [PMC3242923](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3242923).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21910214/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCTClinical Trials

  61. McLendon RE, Adekunle A, Rajaram V, **Blaney SM** , Ko?ak M. Embryonal central nervous system neoplasms arising in infants and young children: a pediatric brain tumor consortium study. Arch Pathol Lab Med. 2011 Aug; 135(8):984-93. PMID: [21809989](//www.ncbi.nlm.nih.gov/pubmed/21809989); PMCID: [PMC3752842](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3752842).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21809989/citedby/) Fields:

Pat Pathology

Translation:HumansCTClinical Trials

  62. Jakacki RI, Bouffet E, Adamson PC, Pollack IF, Ingle AM, Voss SD, **Blaney SM**. A phase 1 study of vinblastine in combination with carboplatin for children with low-grade gliomas: a Children's Oncology Group phase 1 consortium study. Neuro Oncol. 2011 Aug; 13(8):910-5. PMID: [21764821](//www.ncbi.nlm.nih.gov/pubmed/21764821); PMCID: [PMC3145477](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3145477).

Citations:
[13](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21764821/citedby/) Fields:

Neo NeoplasmsNeu Neurology

Translation:HumansCTClinical Trials

  63. Dubois SG, Shusterman S, Ingle AM, Ahern CH, Reid JM, Wu B, Baruchel S, Glade-Bender J, Ivy P, Grier HE, Adamson PC, **Blaney SM**. Phase I and pharmacokinetic study of sunitinib in pediatric patients with refractory solid tumors: a children's oncology group study. Clin Cancer Res. 2011 Aug 01; 17(15):5113-22. PMID: [21690570](//www.ncbi.nlm.nih.gov/pubmed/21690570); PMCID: [PMC3149978](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3149978).

Citations:
[48](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21690570/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  64. Rajagopal MU, Hathout Y, MacDonald TJ, Kieran MW, Gururangan S, **Blaney SM** , Phillips P, Packer R, Gordish-Dressman H, Rood BR. Proteomic profiling of cerebrospinal fluid identifies prostaglandin D2 synthase as a putative biomarker for pediatric medulloblastoma: A pediatric brain tumor consortium study. Proteomics. 2011 Mar; 11(5):935-43. PMID: [21271676](//www.ncbi.nlm.nih.gov/pubmed/21271676); PMCID: [PMC3088509](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3088509).

Citations:
[21](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21271676/citedby/) Fields:

Bio Biochemistry

Translation:HumansCells

  65. Aplenc R, **Blaney SM** , Strauss LC, Balis FM, Shusterman S, Ingle AM, Agrawal S, Sun J, Wright JJ, Adamson PC. Pediatric phase I trial and pharmacokinetic study of dasatinib: a report from the children's oncology group phase I consortium. J Clin Oncol. 2011 Mar 01; 29(7):839-44. PMID: [21263099](//www.ncbi.nlm.nih.gov/pubmed/21263099); PMCID: [PMC3068059](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3068059).

Citations:
[40](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21263099/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  66. [Berg SL](https://profiles.viictr.org/profile/266981), Cairo MS, [Russell H](https://profiles.viictr.org/profile/267675), Ayello J, Ingle AM, Lau H, Chen N, Adamson PC, **Blaney SM**. Safety, pharmacokinetics, and immunomodulatory effects of lenalidomide in children and adolescents with relapsed/refractory solid tumors or myelodysplastic syndrome: a Children's Oncology Group Phase I Consortium report. J Clin Oncol. 2011 Jan 20; 29(3):316-23. PMID: [21149673](//www.ncbi.nlm.nih.gov/pubmed/21149673); PMCID: [PMC3056465](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3056465).

Citations:
[28](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21149673/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  67. Warren KE, Goldman S, Pollack IF, Fangusaro J, Schaiquevich P, Stewart CF, Wallace D, **Blaney SM** , Packer R, Macdonald T, Jakacki R, Boyett JM, Kun LE. Phase I trial of lenalidomide in pediatric patients with recurrent, refractory, or progressive primary CNS tumors: Pediatric Brain Tumor Consortium study PBTC-018. J Clin Oncol. 2011 Jan 20; 29(3):324-9. PMID: [21149652](//www.ncbi.nlm.nih.gov/pubmed/21149652); PMCID: [PMC3056466](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3056466).

Citations:
[38](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21149652/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  68. Su JM, Li XN, Thompson P, Ou CN, Ingle AM, [Russell H](https://profiles.viictr.org/profile/267675), Lau CC, Adamson PC, **Blaney SM**. Phase 1 study of valproic acid in pediatric patients with refractory solid or CNS tumors: a children's oncology group report. Clin Cancer Res. 2011 Feb 01; 17(3):589-97. PMID: [21115653](//www.ncbi.nlm.nih.gov/pubmed/21115653); PMCID: [PMC3064523](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3064523).

Citations:
[51](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21115653/citedby/) Fields:

Neo Neoplasms

Translation:HumansCellsCTClinical Trials

  69. Day ES, Thompson PA, Zhang L, Lewinski NA, [Ahmed N](https://profiles.viictr.org/profile/268944), Drezek RA, **Blaney SM** , West JL. Nanoshell-mediated photothermal therapy improves survival in a murine glioma model. J Neurooncol. 2011 Aug; 104(1):55-63. PMID: [21110217](//www.ncbi.nlm.nih.gov/pubmed/21110217); PMCID: [PMC3710584](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3710584).

Citations:
[48](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21110217/citedby/) Fields:

Neo NeoplasmsNeu Neurology

Translation:HumansAnimalsCells

  70. [Russell HV](https://profiles.viictr.org/profile/267675), Groshen SG, Ara T, DeClerck YA, Hawkins R, Jackson HA, Daldrup-Link HE, Marachelian A, Skerjanec A, Park JR, Katzenstein H, Matthay KK, **Blaney SM** , Villablanca JG. A phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: a new approaches to neuroblastoma therapy (NANT) study. Pediatr Blood Cancer. 2011 Aug; 57(2):275-82. PMID: [21671363](//www.ncbi.nlm.nih.gov/pubmed/21671363); PMCID: [PMC3117015](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3117015).

Citations:
[22](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21671363/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCTClinical Trials

  71. Yu L, [Baxter PA](https://profiles.viictr.org/profile/265524), Zhao X, Liu Z, [Wadhwa L](https://profiles.viictr.org/profile/267141), Zhang Y, Su JM, Tan X, Yang J, [Adesina A](https://profiles.viictr.org/profile/268657), Perlaky L, Hurwitz M, Idamakanti N, Police SR, Hallenbeck PL, **Blaney SM** , [Chintagumpala M](https://profiles.viictr.org/profile/268049), [Hurwitz RL](https://profiles.viictr.org/profile/266847), Li XN. A single intravenous injection of oncolytic picornavirus SVV-001 eliminates medulloblastomas in primary tumor-based orthotopic xenograft mouse models. Neuro Oncol. 2011 Jan; 13(1):14-27. PMID: [21075780](//www.ncbi.nlm.nih.gov/pubmed/21075780); PMCID: [PMC3018906](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3018906).

Citations:
[34](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21075780/citedby/) Fields:

Neo NeoplasmsNeu Neurology

Translation:HumansAnimalsCells

  72. George RE, Lahti JM, Adamson PC, Zhu K, Finkelstein D, Ingle AM, Reid JM, Krailo M, Neuberg D, **Blaney SM** , Diller L. Phase I study of decitabine with doxorubicin and cyclophosphamide in children with neuroblastoma and other solid tumors: a Children's Oncology Group study. Pediatr Blood Cancer. 2010 Oct; 55(4):629-38. PMID: [20589651](//www.ncbi.nlm.nih.gov/pubmed/20589651); PMCID: [PMC3025700](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3025700).

Citations:
[21](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20589651/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCellsCTClinical Trials

  73. Widemann BC, Arceci RJ, Jayaprakash N, Fox E, Zannikos P, Goodspeed W, Goodwin A, Wright JJ, **Blaney SM** , Adamson PC, Balis FM. Phase 1 trial and pharmacokinetic study of the farnesyl transferase inhibitor tipifarnib in children and adolescents with refractory leukemias: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2011 Feb; 56(2):226-33. PMID: [20860038](//www.ncbi.nlm.nih.gov/pubmed/20860038); PMCID: [PMC3271115](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3271115).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20860038/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCTClinical Trials

  74. Beaty O, [Berg S](https://profiles.viictr.org/profile/266981), **Blaney S** , Malogolowkin M, Krailo M, Knight R, Schaiquevich P, Stewart C, Chen Z, Nelson M, Voss S, Ivy SP, Adamson PC. A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: a Children's Oncology Group study. Pediatr Blood Cancer. 2010 Sep; 55(3):440-5. PMID: [20658614](//www.ncbi.nlm.nih.gov/pubmed/20658614); PMCID: [PMC4665115](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4665115).

Citations:
[18](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20658614/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCTClinical Trials

  75. Fouladi M, Stewart CF, **Blaney SM** , Onar-Thomas A, Schaiquevich P, Packer RJ, Gajjar A, Kun LE, Boyett JM, Gilbertson RJ. Phase I trial of lapatinib in children with refractory CNS malignancies: a Pediatric Brain Tumor Consortium study. J Clin Oncol. 2010 Sep 20; 28(27):4221-7. PMID: [20713864](//www.ncbi.nlm.nih.gov/pubmed/20713864); PMCID: [PMC2953974](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2953974).

Citations:
[35](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20713864/citedby/) Fields:

Neo Neoplasms

Translation:HumansCellsCTClinical Trials

  76. Souid AK, Dubowy RL, Ingle AM, Conlan MG, Sun J, **Blaney SM** , Adamson PC. A pediatric phase I trial and pharmacokinetic study of ispinesib: a Children's Oncology Group phase I consortium study. Pediatr Blood Cancer. 2010 Dec 15; 55(7):1323-8. PMID: [20712019](//www.ncbi.nlm.nih.gov/pubmed/20712019); PMCID: [PMC3053384](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3053384).

Citations:
[14](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20712019/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCTClinical Trials

  77. Geyer JR, Stewart CF, Kocak M, Broniscer A, Phillips P, Douglas JG, **Blaney SM** , Packer RJ, Gururangan S, Banerjee A, Kieran MW, Kun LE, Gilbertson RJ, Boyett JM. A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas. Eur J Cancer. 2010 Dec; 46(18):3287-93. PMID: [20708924](//www.ncbi.nlm.nih.gov/pubmed/20708924); PMCID: [PMC2988095](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2988095).

Citations:
[26](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20708924/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  78. [Berg SL](https://profiles.viictr.org/profile/266981), Winick N, Ingle AM, Adamson PC, **Blaney SM**. Reasons for participation in optional pharmacokinetic studies in children with cancer: a Children's Oncology Group phase 1 consortium study. Pediatr Blood Cancer. 2010 Jul 15; 55(1):119-22. PMID: [20486176](//www.ncbi.nlm.nih.gov/pubmed/20486176); PMCID: [PMC2911979](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2911979).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20486176/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:Humans

  79. Fouladi M, Park JR, Stewart CF, Gilbertson RJ, Schaiquevich P, Sun J, Reid JM, Ames MM, Speights R, Ingle AM, Zwiebel J, **Blaney SM** , Adamson PC. Pediatric phase I trial and pharmacokinetic study of vorinostat: a Children's Oncology Group phase I consortium report. J Clin Oncol. 2010 Aug 01; 28(22):3623-9. PMID: [20606092](//www.ncbi.nlm.nih.gov/pubmed/20606092); PMCID: [PMC2917318](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2917318).

Citations:
[92](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20606092/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  80. [Baxter PA](https://profiles.viictr.org/profile/265524), Thompson PA, McGuffey LM, Gibson BW, Dauser RC, [Nuchtern JG](https://profiles.viictr.org/profile/266271), Shi C, Inloes R, Choy G, Redkar S, **Blaney SM**. Plasma and cerebrospinal fluid pharmacokinetics of MP470 in non-human primates. Cancer Chemother Pharmacol. 2011 Apr; 67(4):809-12. PMID: [20563581](//www.ncbi.nlm.nih.gov/pubmed/20563581).

Citations:  Fields:

Ant Antineoplastic AgentsNeo Neoplasms

Translation:Animals

  81. Wagner LM, Perentesis JP, Reid JM, Ames MM, Safgren SL, Nelson MD, Ingle AM, **Blaney SM** , Adamson PC. Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: a Children's Oncology Group phase I consortium study. Pediatr Blood Cancer. 2010 Apr; 54(4):538-45. PMID: [20049936](//www.ncbi.nlm.nih.gov/pubmed/20049936); PMCID: [PMC3074342](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3074342).

Citations:
[20](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20049936/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCTClinical Trials

  82. Yu L, [Baxter PA](https://profiles.viictr.org/profile/265524), Voicu H, Gurusiddappa S, Zhao Y, [Adesina A](https://profiles.viictr.org/profile/268657), [Man TK](https://profiles.viictr.org/profile/266960), Shu Q, Zhang YJ, Zhao XM, Su JM, Perlaky L, [Dauser R](https://profiles.viictr.org/profile/268165), [Chintagumpala M](https://profiles.viictr.org/profile/268049), Lau CC, **Blaney SM** , Rao PH, Leung HC, Li XN. A clinically relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves cancer stem cells in vivo. Neuro Oncol. 2010 Jun; 12(6):580-94. PMID: [20511191](//www.ncbi.nlm.nih.gov/pubmed/20511191); PMCID: [PMC2940646](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2940646).

Citations:
[52](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20511191/citedby/) Fields:

Neo NeoplasmsNeu Neurology

Translation:HumansAnimalsCells

  83. Jacobs S, Fox E, Krailo M, Hartley G, Navid F, Wexler L, **Blaney SM** , Goodwin A, Goodspeed W, Balis FM, Adamson PC, Widemann BC. Phase II trial of ixabepilone administered daily for five days in children and young adults with refractory solid tumors: a report from the children's oncology group. Clin Cancer Res. 2010 Jan 15; 16(2):750-4. PMID: [20068084](//www.ncbi.nlm.nih.gov/pubmed/20068084); PMCID: [PMC3086796](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3086796).

Citations:
[20](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20068084/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  84. [Horton TM](https://profiles.viictr.org/profile/266755), Jenkins G, [Pati D](https://profiles.viictr.org/profile/266988), Zhang L, Dolan ME, Ribes-Zamora A, [Bertuch AA](https://profiles.viictr.org/profile/266270), **Blaney SM** , Delaney SL, Hegde M, [Berg SL](https://profiles.viictr.org/profile/266981). Poly(ADP-ribose) polymerase inhibitor ABT-888 potentiates the cytotoxic activity of temozolomide in leukemia cells: influence of mismatch repair status and O6-methylguanine-DNA methyltransferase activity. Mol Cancer Ther. 2009 Aug; 8(8):2232-42. PMID: [19671751](//www.ncbi.nlm.nih.gov/pubmed/19671751); PMCID: [PMC3741063](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3741063).

Citations:
[35](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19671751/citedby/) Fields:

Ant Antineoplastic Agents

Translation:HumansCells

  85. Muscal JA, Thompson PA, Giranda VL, Dayton BD, Bauch J, [Horton T](https://profiles.viictr.org/profile/266755), McGuffey L, [Nuchtern JG](https://profiles.viictr.org/profile/266271), [Dauser RC](https://profiles.viictr.org/profile/268165), [Gibson BW](https://profiles.viictr.org/profile/268431), **Blaney SM** , Su JM. Plasma and cerebrospinal fluid pharmacokinetics of ABT-888 after oral administration in non-human primates. Cancer Chemother Pharmacol. 2010 Feb; 65(3):419-25. PMID: [19526240](//www.ncbi.nlm.nih.gov/pubmed/19526240); PMCID: [PMC2953793](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2953793).

Citations:
[13](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19526240/citedby/) Fields:

Ant Antineoplastic AgentsNeo Neoplasms

Translation:HumansAnimalsCells

  86. McGregor LM, Spunt SL, Furman WL, Stewart CF, Schaiquevich P, Krailo MD, Speights R, Ivy P, Adamson PC, **Blaney SM**. Phase 1 study of oxaliplatin and irinotecan in pediatric patients with refractory solid tumors: a children's oncology group study. Cancer. 2009 Apr 15; 115(8):1765-75. PMID: [19170226](//www.ncbi.nlm.nih.gov/pubmed/19170226); PMCID: [PMC2897817](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2897817).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19170226/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  87. Geller JI, Wall D, Perentesis J, **Blaney SM** , Bernstein M, Pediatric Oncology Group study 9376. Phase I study of paclitaxel with standard dose ifosfamide in children with refractory solid tumors: a Pediatric Oncology Group study (POG 9376). Pediatr Blood Cancer. 2009 Mar; 52(3):346-50. PMID: [18989889](//www.ncbi.nlm.nih.gov/pubmed/18989889); PMCID: [PMC2744894](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2744894).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18989889/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCTClinical Trials

  88. Kieran MW, Supko JG, Wallace D, Fruscio R, Poussaint TY, Phillips P, Pollack I, Packer R, Boyett JM, **Blaney S** , Banerjee A, Geyer R, Friedman H, Goldman S, Kun LE, Macdonald T, Pediatric Brain Tumor Consortium. Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors. Pediatr Blood Cancer. 2009 Feb; 52(2):169-76. PMID: [19065567](//www.ncbi.nlm.nih.gov/pubmed/19065567); PMCID: [PMC2775441](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2775441).

Citations:
[18](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19065567/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCTClinical Trials

  89. Kilburn LB, Bonate PL, **Blaney SM** , McGuffey L, [Nuchtern JG](https://profiles.viictr.org/profile/266271), [Dauser R](https://profiles.viictr.org/profile/268165), Thompson P, [Gibson BW](https://profiles.viictr.org/profile/268431), [Berg SL](https://profiles.viictr.org/profile/266981). Plasma and cerebrospinal fluid pharmacokinetics of tasidotin (ILX-651) and its metabolites in non-human primates. Cancer Chemother Pharmacol. 2009 Jul; 64(2):335-40. PMID: [19043710](//www.ncbi.nlm.nih.gov/pubmed/19043710).

Citations:  Fields:

Ant Antineoplastic AgentsNeo Neoplasms

Translation:Animals

  90. [Bomgaars L](https://profiles.viictr.org/profile/266256), Thompson P, [Berg S](https://profiles.viictr.org/profile/266981), Serabe B, Aleksic A, **Blaney S**. Valacyclovir and acyclovir pharmacokinetics in immunocompromised children. Pediatr Blood Cancer. 2008 Oct; 51(4):504-8. PMID: [18561175](//www.ncbi.nlm.nih.gov/pubmed/18561175); PMCID: [PMC4063282](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4063282).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18561175/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:Humans

  91. Jakacki RI, Hamilton M, Gilbertson RJ, **Blaney SM** , Tersak J, Krailo MD, Ingle AM, Voss SD, Dancey JE, Adamson PC. Pediatric phase I and pharmacokinetic study of erlotinib followed by the combination of erlotinib and temozolomide: a Children's Oncology Group Phase I Consortium Study. J Clin Oncol. 2008 Oct 20; 26(30):4921-7. PMID: [18794549](//www.ncbi.nlm.nih.gov/pubmed/18794549); PMCID: [PMC2652086](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2652086).

Citations:
[52](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18794549/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  92. Bradley KA, Pollack IF, Reid JM, Adamson PC, Ames MM, Vezina G, **Blaney S** , Ivy P, Zhou T, Krailo M, Reaman G, Mehta MP, Children's Oncology Group. Motexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a Children's Oncology Group phase I study. Neuro Oncol. 2008 Oct; 10(5):752-8. PMID: [18715950](//www.ncbi.nlm.nih.gov/pubmed/18715950); PMCID: [PMC2666252](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2666252).

Citations:
[22](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18715950/citedby/) Fields:

Neo NeoplasmsNeu Neurology

Translation:HumansCTClinical Trials

  93. Raetz EA, Cairo MS, Borowitz MJ, **Blaney SM** , Krailo MD, Leil TA, Reid JM, Goldenberg DM, Wegener WA, Carroll WL, Adamson PC, Children's Oncology Group Pilot Study. Chemoimmunotherapy reinduction with epratuzumab in children with acute lymphoblastic leukemia in marrow relapse: a Children's Oncology Group Pilot Study. J Clin Oncol. 2008 Aug 01; 26(22):3756-62. PMID: [18669463](//www.ncbi.nlm.nih.gov/pubmed/18669463); PMCID: [PMC2654811](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2654811).

Citations:
[77](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18669463/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  94. Kim A, Fox E, Warren K, **Blaney SM** , [Berg SL](https://profiles.viictr.org/profile/266981), Adamson PC, Libucha M, Byrley E, Balis FM, Widemann BC. Characteristics and outcome of pediatric patients enrolled in phase I oncology trials. Oncologist. 2008 Jun; 13(6):679-89. PMID: [18586923](//www.ncbi.nlm.nih.gov/pubmed/18586923); PMCID: [PMC6953426](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6953426).

Citations:
[19](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18586923/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  95. Jakacki RI, Yates A, **Blaney SM** , Zhou T, Timmerman R, Ingle AM, Flom L, Prados MD, Adamson PC, Pollack IF. A phase I trial of temozolomide and lomustine in newly diagnosed high-grade gliomas of childhood. Neuro Oncol. 2008 Aug; 10(4):569-76. PMID: [18497327](//www.ncbi.nlm.nih.gov/pubmed/18497327); PMCID: [PMC2666230](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2666230).

Citations:
[12](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18497327/citedby/) Fields:

Neo NeoplasmsNeu Neurology

Translation:HumansCTClinical Trials

  96. Haas-Kogan DA, Banerjee A, Kocak M, Prados MD, Geyer JR, Fouladi M, McKnight T, Poussaint TY, Broniscer A, **Blaney SM** , Boyett JM, Kun LE. Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma. Neuro Oncol. 2008 Jun; 10(3):341-7. PMID: [18417739](//www.ncbi.nlm.nih.gov/pubmed/18417739); PMCID: [PMC2563056](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2563056).

Citations:
[22](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18417739/citedby/) Fields:

Neo NeoplasmsNeu Neurology

Translation:HumansCTClinical Trials

  97. Shu Q, [Wong KK](https://profiles.viictr.org/profile/12583480), Su JM, [Adesina AM](https://profiles.viictr.org/profile/268657), Yu LT, Tsang YT, Antalffy BC, [Baxter P](https://profiles.viictr.org/profile/265524), Perlaky L, Yang J, [Dauser RC](https://profiles.viictr.org/profile/268165), [Chintagumpala M](https://profiles.viictr.org/profile/268049), **Blaney SM** , Lau CC, Li XN. Direct orthotopic transplantation of fresh surgical specimen preserves CD133+ tumor cells in clinically relevant mouse models of medulloblastoma and glioma. Stem Cells. 2008 Jun; 26(6):1414-24. PMID: [18403755](//www.ncbi.nlm.nih.gov/pubmed/18403755).

Citations:
[84](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18403755/citedby/) Fields:

Cel Cell BiologyEmb Embryology

Translation:HumansAnimals

  98. Menon-Andersen D, Mondick JT, Jayaraman B, Thompson PA, **Blaney SM** , Bernstein M, Bond M, Champagne M, Fossler MJ, Barrett JS. Population pharmacokinetics of imatinib mesylate and its metabolite in children and young adults. Cancer Chemother Pharmacol. 2009 Jan; 63(2):229-38. PMID: [18398615](//www.ncbi.nlm.nih.gov/pubmed/18398615).

Citations:
[22](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18398615/citedby/) Fields:

Ant Antineoplastic AgentsNeo Neoplasms

Translation:HumansCTClinical Trials

  99. Jacob E, Scorsone K, **Blaney SM** , D'Argenio DZ, [Berg SL](https://profiles.viictr.org/profile/266981). Synergy of karenitecin and mafosfamide in pediatric leukemia, medulloblastoma, and neuroblastoma cell lines. Pediatr Blood Cancer. 2008 Apr; 50(4):757-60. PMID: [17849472](//www.ncbi.nlm.nih.gov/pubmed/17849472); PMCID: [PMC2975705](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2975705).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17849472/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCells

  100. Adams DM, Zhou T, [Berg SL](https://profiles.viictr.org/profile/266981), Bernstein M, Neville K, **Blaney SM** , Children's Oncology Group. Phase 1 trial of O6-benzylguanine and BCNU in children with CNS tumors: a Children's Oncology Group study. Pediatr Blood Cancer. 2008 Mar; 50(3):549-53. PMID: [17941066](//www.ncbi.nlm.nih.gov/pubmed/17941066).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17941066/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCellsCTClinical Trials

  101. Langevin AM, Bernstein M, Kuhn JG, **Blaney SM** , Ivy P, Sun J, Chen Z, Adamson PC, Children's Oncology Group. A phase II trial of rebeccamycin analogue (NSC #655649) in children with solid tumors: a Children's Oncology Group study. Pediatr Blood Cancer. 2008 Mar; 50(3):577-80. PMID: [17610262](//www.ncbi.nlm.nih.gov/pubmed/17610262).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17610262/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCTClinical Trials

  102. Thompson PA, Gupta M, Rosner GL, Yu A, Barrett J, [Bomgaars L](https://profiles.viictr.org/profile/266256), Bernstein ML, **Blaney SM** , Mondick J. Pharmacokinetics of irinotecan and its metabolites in pediatric cancer patients: a report from the children's oncology group. Cancer Chemother Pharmacol. 2008 Nov; 62(6):1027-37. PMID: [18278496](//www.ncbi.nlm.nih.gov/pubmed/18278496).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18278496/citedby/) Fields:

Ant Antineoplastic AgentsNeo Neoplasms

Translation:Humans

  103. Gururangan S, Turner CD, Stewart CF, O'Shaughnessy M, Kocak M, Poussaint TY, Phillips PC, Goldman S, Packer R, Pollack IF, **Blaney SM** , Karsten V, Gerson SL, Boyett JM, Friedman HS, Kun LE. Phase I trial of VNP40101M (Cloretazine) in children with recurrent brain tumors: a pediatric brain tumor consortium study. Clin Cancer Res. 2008 Feb 15; 14(4):1124-30. PMID: [18281546](//www.ncbi.nlm.nih.gov/pubmed/18281546).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18281546/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  104. Bond M, Bernstein ML, Pappo A, Schultz KR, Krailo M, **Blaney SM** , Adamson PC. A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: a Children's Oncology Group study. Pediatr Blood Cancer. 2008 Feb; 50(2):254-8. PMID: [17262795](//www.ncbi.nlm.nih.gov/pubmed/17262795).

Citations:
[73](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17262795/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCTClinical Trials

  105. Glade Bender JL, Adamson PC, Reid JM, Xu L, Baruchel S, Shaked Y, Kerbel RS, Cooney-Qualter EM, Stempak D, Chen HX, Nelson MD, Krailo MD, Ingle AM, **Blaney SM** , Kandel JJ, Yamashiro DJ, Children's Oncology Group Study. Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: a Children's Oncology Group Study. J Clin Oncol. 2008 Jan 20; 26(3):399-405. PMID: [18202416](//www.ncbi.nlm.nih.gov/pubmed/18202416).

Citations:
[93](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18202416/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  106. [Horton TM](https://profiles.viictr.org/profile/266755), Thompson PA, [Berg SL](https://profiles.viictr.org/profile/266981), Adamson PC, Ingle AM, Dolan ME, Delaney SM, Hedge M, Weiss HL, Wu MF, **Blaney SM** , Children's Oncology Group Study. Phase I pharmacokinetic and pharmacodynamic study of temozolomide in pediatric patients with refractory or recurrent leukemia: a Children's Oncology Group Study. J Clin Oncol. 2007 Nov 01; 25(31):4922-8. PMID: [17971589](//www.ncbi.nlm.nih.gov/pubmed/17971589); PMCID: [PMC6684202](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6684202).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17971589/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  107. Fox E, Razzouk BI, Widemann BC, Xiao S, O'Brien M, Goodspeed W, Reaman GH, **Blaney SM** , Murgo AJ, Balis FM, Adamson PC. Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma. Blood. 2008 Jan 15; 111(2):566-73. PMID: [17959855](//www.ncbi.nlm.nih.gov/pubmed/17959855); PMCID: [PMC2200837](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2200837).

Citations:
[37](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17959855/citedby/) Fields:

Hem Hematology

Translation:HumansCTClinical Trials

  108. [Bomgaars LR](https://profiles.viictr.org/profile/266256), Bernstein M, Krailo M, Kadota R, Das S, Chen Z, Adamson PC, **Blaney SM**. Phase II trial of irinotecan in children with refractory solid tumors: a Children's Oncology Group Study. J Clin Oncol. 2007 Oct 10; 25(29):4622-7. PMID: [17925558](//www.ncbi.nlm.nih.gov/pubmed/17925558).

Citations:
[50](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17925558/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  109. Bernardi RJ, [Bomgaars L](https://profiles.viictr.org/profile/266256), Fox E, Balis FM, Egorin MJ, Lagattuta TF, Aikin A, Whitcomb P, Renbarger J, Lieberman FS, [Berg SL](https://profiles.viictr.org/profile/266981), **Blaney SM**. Phase I clinical trial of intrathecal gemcitabine in patients with neoplastic meningitis. Cancer Chemother Pharmacol. 2008 Jul; 62(2):355-61. PMID: [17909804](//www.ncbi.nlm.nih.gov/pubmed/17909804).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17909804/citedby/) Fields:

Ant Antineoplastic AgentsNeo Neoplasms

Translation:HumansCTClinical Trials

  110. Bernardi RJ, Lowery AR, Thompson PA, **Blaney SM** , West JL. Immunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: an in vitro evaluation using human cell lines. J Neurooncol. 2008 Jan; 86(2):165-72. PMID: [17805488](//www.ncbi.nlm.nih.gov/pubmed/17805488).

Citations:
[47](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17805488/citedby/) Fields:

Neo NeoplasmsNeu Neurology

Translation:HumansCells

  111. Jimeno A, Daw NC, Amador ML, Cusatis G, Kulesza P, Krailo M, Ingle AM, **Blaney SM** , Adamson P, Hidalgo M, Children's Oncology Group. Analysis of biologic surrogate markers from a Children's Oncology Group Phase I trial of gefitinib in pediatric patients with solid tumors. Pediatr Blood Cancer. 2007 Sep; 49(3):352-7. PMID: [16425266](//www.ncbi.nlm.nih.gov/pubmed/16425266).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16425266/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCTClinical Trials

  112. Kieran MW, Packer RJ, Onar A, **Blaney SM** , Phillips P, Pollack IF, Geyer JR, Gururangan S, Banerjee A, Goldman S, Turner CD, Belasco JB, Broniscer A, Zhu Y, Frank E, Kirschmeier P, Statkevich P, Yver A, Boyett JM, Kun LE. Phase I and pharmacokinetic study of the oral farnesyltransferase inhibitor lonafarnib administered twice daily to pediatric patients with advanced central nervous system tumors using a modified continuous reassessment method: a Pediatric Brain Tumor Consortium Study. J Clin Oncol. 2007 Jul 20; 25(21):3137-43. PMID: [17634493](//www.ncbi.nlm.nih.gov/pubmed/17634493).

Citations:
[31](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17634493/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  113. Stapleton SL, Thompson PA, Ou CN, [Berg SL](https://profiles.viictr.org/profile/266981), McGuffey L, [Gibson B](https://profiles.viictr.org/profile/268431), **Blaney SM**. Plasma and cerebrospinal fluid pharmacokinetics of valproic acid after oral administration in non-human primates. Cancer Chemother Pharmacol. 2008 Apr; 61(4):647-52. PMID: [17541590](//www.ncbi.nlm.nih.gov/pubmed/17541590).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17541590/citedby/) Fields:

Ant Antineoplastic AgentsNeo Neoplasms

Translation:Animals

  114. Malempati S, Nicholson HS, Reid JM, **Blaney SM** , Ingle AM, Krailo M, Stork LC, Melemed AS, McGovern R, Safgren S, Ames MM, Adamson PC, Children's Oncology Group. Phase I trial and pharmacokinetic study of pemetrexed in children with refractory solid tumors: the Children's Oncology Group. J Clin Oncol. 2007 Apr 20; 25(12):1505-11. PMID: [17442992](//www.ncbi.nlm.nih.gov/pubmed/17442992).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17442992/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  115. Rheingold SR, Hogarty MD, **Blaney SM** , Zwiebel JA, Sauk-Schubert C, Chandula R, Krailo MD, Adamson PC, Children's Oncology Group Study. Phase I Trial of G3139, a bcl-2 antisense oligonucleotide, combined with doxorubicin and cyclophosphamide in children with relapsed solid tumors: a Children's Oncology Group Study. J Clin Oncol. 2007 Apr 20; 25(12):1512-8. PMID: [17442993](//www.ncbi.nlm.nih.gov/pubmed/17442993).

Citations:
[12](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17442993/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  116. Weigel BJ, **Blaney SM** , Reid JM, Safgren SL, Bagatell R, Kersey J, Neglia JP, Ivy SP, Ingle AM, Whitesell L, Gilbertson RJ, Krailo M, Ames M, Adamson PC. A phase I study of 17-allylaminogeldanamycin in relapsed/refractory pediatric patients with solid tumors: a Children's Oncology Group study. Clin Cancer Res. 2007 Mar 15; 13(6):1789-93. PMID: [17363534](//www.ncbi.nlm.nih.gov/pubmed/17363534).

Citations:
[29](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17363534/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  117. [Horton TM](https://profiles.viictr.org/profile/266755), [Pati D](https://profiles.viictr.org/profile/266988), [Plon SE](https://profiles.viictr.org/profile/269771), Thompson PA, [Bomgaars LR](https://profiles.viictr.org/profile/266256), Adamson PC, Ingle AM, Wright J, Brockman AH, Paton M, **Blaney SM**. A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group study. Clin Cancer Res. 2007 Mar 01; 13(5):1516-22. PMID: [17332297](//www.ncbi.nlm.nih.gov/pubmed/17332297).

Citations:
[61](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17332297/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  118. Pollack IF, Jakacki RI, **Blaney SM** , Hancock ML, Kieran MW, Phillips P, Kun LE, Friedman H, Packer R, Banerjee A, Geyer JR, Goldman S, Poussaint TY, Krasin MJ, Wang Y, Hayes M, Murgo A, Weiner S, Boyett JM. Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report. Neuro Oncol. 2007 Apr; 9(2):145-60. PMID: [17293590](//www.ncbi.nlm.nih.gov/pubmed/17293590); PMCID: [PMC1871662](//www.ncbi.nlm.nih.gov/pmc/articles/PMC1871662).

Citations:
[78](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17293590/citedby/) Fields:

Neo NeoplasmsNeu Neurology

Translation:HumansCTClinical Trials

  119. Li XN, Shu Q, [Su JM](https://profiles.viictr.org/profile/268196), Adesina AM, Wong KK, Perlaky L, Antalffy BA, **Blaney SM** , Lau CC. Differential expression of survivin splice isoforms in medulloblastomas. Neuropathol Appl Neurobiol. 2007 Feb; 33(1):67-76. PMID: [17239009](//www.ncbi.nlm.nih.gov/pubmed/17239009).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17239009/citedby/) Fields:

Bio BiologyNeu NeurologyPat Pathology

Translation:HumansCells

  120. Thompson PA, Murry DJ, Rosner GL, Lunagomez S, **Blaney SM** , [Berg SL](https://profiles.viictr.org/profile/266981), Camitta BM, [Dreyer ZE](https://profiles.viictr.org/profile/269653), [Bomgaars LR](https://profiles.viictr.org/profile/266256). Methotrexate pharmacokinetics in infants with acute lymphoblastic leukemia. Cancer Chemother Pharmacol. 2007 May; 59(6):847-53. PMID: [17136402](//www.ncbi.nlm.nih.gov/pubmed/17136402).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17136402/citedby/) Fields:

Ant Antineoplastic AgentsNeo Neoplasms

Translation:HumansCTClinical Trials

  121. Hawkins DS, Bradfield S, Whitlock JA, Krailo M, Franklin J, **Blaney SM** , Adamson PC, Reaman G. Topotecan by 21-day continuous infusion in children with relapsed or refractory solid tumors: a Children's Oncology Group study. Pediatr Blood Cancer. 2006 Nov; 47(6):790-4. PMID: [16435380](//www.ncbi.nlm.nih.gov/pubmed/16435380).

Citations:
[16](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16435380/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCTClinical Trials

  122. Fouladi M, **Blaney SM** , Poussaint TY, Freeman BB, McLendon R, Fuller C, [Adesina AM](https://profiles.viictr.org/profile/268657), Hancock ML, Danks MK, Stewart C, Boyett JM, Gajjar A. Phase II study of oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid tumors: a pediatric brain tumor consortium study. Cancer. 2006 Nov 01; 107(9):2291-7. PMID: [17019740](//www.ncbi.nlm.nih.gov/pubmed/17019740).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17019740/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  123. [Berg SL](https://profiles.viictr.org/profile/266981), Brueckner C, [Nuchtern JG](https://profiles.viictr.org/profile/266271), [Dauser R](https://profiles.viictr.org/profile/268165), McGuffey L, **Blaney SM**. Plasma and cerebrospinal fluid pharmacokinetics of nelarabine in nonhuman primates. Cancer Chemother Pharmacol. 2007 May; 59(6):743-7. PMID: [16953392](//www.ncbi.nlm.nih.gov/pubmed/16953392).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16953392/citedby/) Fields:

Ant Antineoplastic AgentsNeo Neoplasms

Translation:Animals

  124. Children's Oncology Group, Fouladi M, Furman WL, Chin T, Freeman BB, Dudkin L, Stewart CF, Krailo MD, Speights R, Ingle AM, Houghton PJ, Wright J, Adamson PC, **Blaney SM**. Phase I study of depsipeptide in pediatric patients with refractory solid tumors: a Children's Oncology Group report. J Clin Oncol. 2006 Aug 01; 24(22):3678-85. PMID: [16877737](//www.ncbi.nlm.nih.gov/pubmed/16877737).

Citations:
[28](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16877737/citedby/) Fields:

Neo Neoplasms

Translation:HumansCellsCTClinical Trials

  125. Stapleton S, **Blaney S**. New agents for intrathecal administration. Cancer Invest. 2006 Aug-Sep; 24(5):528-34. PMID: [16939963](//www.ncbi.nlm.nih.gov/pubmed/16939963).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16939963/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimals

  126. Shu Q, Antalffy B, Su JM, [Adesina A](https://profiles.viictr.org/profile/268657), Ou CN, Pietsch T, **Blaney SM** , Lau CC, Li XN. Valproic Acid prolongs survival time of severe combined immunodeficient mice bearing intracerebellar orthotopic medulloblastoma xenografts. Clin Cancer Res. 2006 Aug 01; 12(15):4687-94. PMID: [16899619](//www.ncbi.nlm.nih.gov/pubmed/16899619).

Citations:
[33](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16899619/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  127. [Bomgaars LR](https://profiles.viictr.org/profile/266256), Megason GC, Pullen J, Langevin AM, Dale Weitman S, Hershon L, Kuhn JG, Bernstein M, **Blaney SM**. Phase I trial of irofulven (MGI 114) in pediatric patients with solid tumors. Pediatr Blood Cancer. 2006 Aug; 47(2):163-8. PMID: [16317728](//www.ncbi.nlm.nih.gov/pubmed/16317728).

Citations:  Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCTClinical Trials

  128. Stapleton SL, Reid JM, Thompson PA, Ames MM, McGovern RM, McGuffey L, [Nuchtern J](https://profiles.viictr.org/profile/266271), [Dauser R](https://profiles.viictr.org/profile/268165), **Blaney SM**. Plasma and cerebrospinal fluid pharmacokinetics of pemetrexed after intravenous administration in non-human primates. Cancer Chemother Pharmacol. 2007 Mar; 59(4):461-6. PMID: [16855840](//www.ncbi.nlm.nih.gov/pubmed/16855840).

Citations:
[14](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16855840/citedby/) Fields:

Ant Antineoplastic AgentsNeo Neoplasms

Translation:AnimalsCells

  129. [Chintagumpala MM](https://profiles.viictr.org/profile/268049), Friedman HS, Stewart CF, Kepner J, McLendon RE, Modrich PL, McCluggage C, Burger P, Holmes E, Thompson S, Rutka J, Michalski J, Woo S, **Blaney SM** , Kun LE, Horowitz ME, Pediatric Oncology Group Study. A phase II window trial of procarbazine and topotecan in children with high-grade glioma: a report from the children's oncology group. J Neurooncol. 2006 Apr; 77(2):193-8. PMID: [16314955](//www.ncbi.nlm.nih.gov/pubmed/16314955).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16314955/citedby/) Fields:

Neo NeoplasmsNeu Neurology

Translation:HumansCTClinical Trials

  130. Gururangan S, Petros WP, Poussaint TY, Hancock ML, Phillips PC, Friedman HS, [Bomgaars L](https://profiles.viictr.org/profile/266256), **Blaney SM** , Kun LE, Boyett JM. Phase I trial of intrathecal spartaject busulfan in children with neoplastic meningitis: a Pediatric Brain Tumor Consortium Study (PBTC-004). Clin Cancer Res. 2006 Mar 01; 12(5):1540-6. PMID: [16533779](//www.ncbi.nlm.nih.gov/pubmed/16533779).

Citations:
[13](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16533779/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  131. Widemann BC, Salzer WL, Arceci RJ, **Blaney SM** , Fox E, End D, Gillespie A, Whitcomb P, Palumbo JS, Pitney A, Jayaprakash N, Zannikos P, Balis FM. Phase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromas. J Clin Oncol. 2006 Jan 20; 24(3):507-16. PMID: [16421428](//www.ncbi.nlm.nih.gov/pubmed/16421428).

Citations:
[56](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16421428/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  132. [Bomgaars L](https://profiles.viictr.org/profile/266256), Kerr J, Berg S, Kuttesch J, Klenke R, **Blaney SM**. A phase I study of irinotecan administered on a weekly schedule in pediatric patients. Pediatr Blood Cancer. 2006 Jan; 46(1):50-5. PMID: [15768380](//www.ncbi.nlm.nih.gov/pubmed/15768380).

Citations:
[14](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15768380/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCTClinical Trials

  133. Li XN, Shu Q, Su JM, Perlaky L, **Blaney SM** , Lau CC. Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC. Mol Cancer Ther. 2005 Dec; 4(12):1912-22. PMID: [16373706](//www.ncbi.nlm.nih.gov/pubmed/16373706).

Citations:
[70](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16373706/citedby/) Fields:

Ant Antineoplastic Agents

Translation:HumansAnimalsCells

  134. [Horton TM](https://profiles.viictr.org/profile/266755), Gannavarapu A, **Blaney SM** , D'Argenio DZ, [Plon SE](https://profiles.viictr.org/profile/269771), [Berg SL](https://profiles.viictr.org/profile/266981). Bortezomib interactions with chemotherapy agents in acute leukemia in vitro. Cancer Chemother Pharmacol. 2006 Jul; 58(1):13-23. PMID: [16292537](//www.ncbi.nlm.nih.gov/pubmed/16292537).

Citations:
[41](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16292537/citedby/) Fields:

Ant Antineoplastic AgentsNeo Neoplasms

Translation:HumansCells

  135. Greenberg ML, Fisher PG, Freeman C, Korones DN, Bernstein M, Friedman H, **Blaney S** , Hershon L, Zhou T, Chen Z, Kretschmar C. Etoposide, vincristine, and cyclosporin A with standard-dose radiation therapy in newly diagnosed diffuse intrinsic brainstem gliomas: a pediatric oncology group phase I study. Pediatr Blood Cancer. 2005 Oct 15; 45(5):644-8. PMID: [16110498](//www.ncbi.nlm.nih.gov/pubmed/16110498).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16110498/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCTClinical Trials

  136. Daw NC, Furman WL, Stewart CF, Iacono LC, Krailo M, Bernstein ML, Dancey JE, Speights RA, **Blaney SM** , Croop JM, Reaman GH, Adamson PC, Children's Oncology Group. Phase I and pharmacokinetic study of gefitinib in children with refractory solid tumors: a Children's Oncology Group Study. J Clin Oncol. 2005 Sep 01; 23(25):6172-80. PMID: [16135484](//www.ncbi.nlm.nih.gov/pubmed/16135484).

Citations:
[35](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16135484/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  137. [Berg SL](https://profiles.viictr.org/profile/266981), Bonate PL, [Nuchtern JG](https://profiles.viictr.org/profile/266271), [Dauser R](https://profiles.viictr.org/profile/268165), McGuffey L, Bernacky B, **Blaney SM**. Plasma and cerebrospinal fluid pharmacokinetics of clofarabine in nonhuman primates. Clin Cancer Res. 2005 Aug 15; 11(16):5981-3. PMID: [16115942](//www.ncbi.nlm.nih.gov/pubmed/16115942).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16115942/citedby/) Fields:

Neo Neoplasms

Translation:Animals

  138. Adamson PC, **Blaney SM**. New approaches to drug development in pediatric oncology. Cancer J. 2005 Jul-Aug; 11(4):324-30. PMID: [16197722](//www.ncbi.nlm.nih.gov/pubmed/16197722).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16197722/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  139. [Berg SL](https://profiles.viictr.org/profile/266981), **Blaney SM** , Devidas M, Lampkin TA, Murgo A, Bernstein M, Billett A, Kurtzberg J, Reaman G, Gaynon P, Whitlock J, Krailo M, Harris MB, Children's Oncology Group. Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group. J Clin Oncol. 2005 May 20; 23(15):3376-82. PMID: [15908649](//www.ncbi.nlm.nih.gov/pubmed/15908649).

Citations:
[71](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15908649/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  140. **Blaney SM** , Balis FM, [Berg S](https://profiles.viictr.org/profile/266981), Arndt CA, Heideman R, Geyer JR, Packer R, Adamson PC, Jaeckle K, Klenke R, Aikin A, Murphy R, McCully C, [Poplack DG](https://profiles.viictr.org/profile/268156). Intrathecal mafosfamide: a preclinical pharmacology and phase I trial. J Clin Oncol. 2005 Mar 01; 23(7):1555-63. PMID: [15735131](//www.ncbi.nlm.nih.gov/pubmed/15735131).

Citations:
[13](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15735131/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCTClinical Trials

  141. Tekautz TM, Fuller CE, **Blaney S** , Fouladi M, Broniscer A, Merchant TE, Krasin M, Dalton J, Hale G, Kun LE, Wallace D, Gilbertson RJ, Gajjar A. Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy. J Clin Oncol. 2005 Mar 01; 23(7):1491-9. PMID: [15735125](//www.ncbi.nlm.nih.gov/pubmed/15735125).

Citations:
[128](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15735125/citedby/)
Fields:

Neo Neoplasms

Translation:Humans

  142. [Horton TM](https://profiles.viictr.org/profile/266755), **Blaney SM** , Langevin AM, Kuhn J, Kamen B, [Berg SL](https://profiles.viictr.org/profile/266981), Bernstein M, Weitman S. Phase I trial and pharmacokinetic study of raltitrexed in children with recurrent or refractory leukemia: a pediatric oncology group study. Clin Cancer Res. 2005 Mar 01; 11(5):1884-9. PMID: [15756014](//www.ncbi.nlm.nih.gov/pubmed/15756014).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15756014/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  143. **Blaney SM** , Boyett J, Friedman H, Gajjar A, Geyer R, Horowtiz M, Hunt D, Kieran M, Kun L, Packer R, Phillips P, Pollack IF, Prados M, Heideman R. Phase I clinical trial of mafosfamide in infants and children aged 3 years or younger with newly diagnosed embryonal tumors: a pediatric brain tumor consortium study (PBTC-001). J Clin Oncol. 2005 Jan 20; 23(3):525-31. PMID: [15659498](//www.ncbi.nlm.nih.gov/pubmed/15659498).

Citations:
[12](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15659498/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  144. Lau L, Supko JG, **Blaney S** , Hershon L, Seibel N, Krailo M, Qu W, Malkin D, Jimeno J, Bernstein M, Baruchel S. A phase I and pharmacokinetic study of ecteinascidin-743 (Yondelis) in children with refractory solid tumors. A Children's Oncology Group study. Clin Cancer Res. 2005 Jan 15; 11(2 Pt 1):672-7. PMID: [15701855](//www.ncbi.nlm.nih.gov/pubmed/15701855).

Citations:
[22](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15701855/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  145. [Wong KK](https://profiles.viictr.org/profile/12583480), Chang YM, Tsang YT, Perlaky L, [Su J](https://profiles.viictr.org/profile/268196), [Adesina A](https://profiles.viictr.org/profile/268657), Armstrong DL, Bhattacharjee M, [Dauser R](https://profiles.viictr.org/profile/268165), **Blaney SM** , [Chintagumpala M](https://profiles.viictr.org/profile/268049), Lau CC. Expression analysis of juvenile pilocytic astrocytomas by oligonucleotide microarray reveals two potential subgroups. Cancer Res. 2005 Jan 01; 65(1):76-84. PMID: [15665281](//www.ncbi.nlm.nih.gov/pubmed/15665281).

Citations:
[27](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15665281/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  146. Neville KA, **Blaney SM**. Leptomeningeal cancer in the pediatric patient. Cancer Treat Res. 2005; 125:87-106. PMID: [16211885](//www.ncbi.nlm.nih.gov/pubmed/16211885).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16211885/citedby/) Fields:

Neo NeoplasmsThe Therapeutics

Translation:Humans

  147. Jeha S, [Kantarjian H](https://profiles.viictr.org/profile/12582901), Irwin D, Shen V, Shenoy S, **Blaney S** , Camitta B, Pui CH. Efficacy and safety of rasburicase, a recombinant urate oxidase (Elitek), in the management of malignancy-associated hyperuricemia in pediatric and adult patients: final results of a multicenter compassionate use trial. Leukemia. 2005 Jan; 19(1):34-8. PMID: [15510203](//www.ncbi.nlm.nih.gov/pubmed/15510203).

Citations:
[33](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15510203/citedby/) Fields:

Hem HematologyNeo Neoplasms

Translation:Humans

  148. **Blaney SM** , Bernstein M, Neville K, Ginsberg J, Kitchen B, [Horton T](https://profiles.viictr.org/profile/266755), [Berg SL](https://profiles.viictr.org/profile/266981), Krailo M, Adamson PC. Phase I study of the proteasome inhibitor bortezomib in pediatric patients with refractory solid tumors: a Children's Oncology Group study (ADVL0015). J Clin Oncol. 2004 Dec 01; 22(23):4804-9. PMID: [15570082](//www.ncbi.nlm.nih.gov/pubmed/15570082).

Citations:
[35](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15570082/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  149. [Chintagumpala M](https://profiles.viictr.org/profile/268049), **Blaney SM** , [Bomgaars LR](https://profiles.viictr.org/profile/266256), Aleksic A, Kuttesch JF, Klenke RA, [Berg SL](https://profiles.viictr.org/profile/266981). Phase I and pharmacokinetic study of thalidomide with carboplatin in children with cancer. J Clin Oncol. 2004 Nov 01; 22(21):4394-400. PMID: [15514381](//www.ncbi.nlm.nih.gov/pubmed/15514381).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15514381/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  150. Zhang L, [Plon SE](https://profiles.viictr.org/profile/269771), [Nuchtern JG](https://profiles.viictr.org/profile/266271), Burlingame S, **Blaney S** , Rousseau R, [Berg S](https://profiles.viictr.org/profile/266981). Cyclin D and cisplatin cytotoxicity in primary neuroblastoma cell lines. Anticancer Drugs. 2004 Oct; 15(9):883-8. PMID: [15457129](//www.ncbi.nlm.nih.gov/pubmed/15457129).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15457129/citedby/) Fields:

Ant Antineoplastic Agents

Translation:HumansCells

  151. [Bomgaars L](https://profiles.viictr.org/profile/266256), Geyer JR, Franklin J, Dahl G, Park J, Winick NJ, Klenke R, Berg SL, **Blaney SM**. Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis. J Clin Oncol. 2004 Oct 01; 22(19):3916-21. PMID: [15459213](//www.ncbi.nlm.nih.gov/pubmed/15459213).

Citations:
[39](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15459213/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  152. Neville K, **Blaney S** , Bernstein M, Thompson P, Adams D, Aleksic A, [Berg S](https://profiles.viictr.org/profile/266981). Pharmacokinetics of O(6)-benzylguanine in pediatric patients with central nervous system tumors: a pediatric oncology group study. Clin Cancer Res. 2004 Aug 01; 10(15):5072-5. PMID: [15297409](//www.ncbi.nlm.nih.gov/pubmed/15297409).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15297409/citedby/) Fields:

Neo Neoplasms

Translation:HumansCellsCTClinical Trials

  153. Capdeville R, Krailo M, Qu W, Peng B, Rosamilia M, Therrien M, Zoellner U, **Blaney SM** , Bernstein M, Children's Oncology Group phase 1 study, Champagne MA. Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children's Oncology Group phase 1 study. Blood. 2004 Nov 01; 104(9):2655-60. PMID: [15231574](//www.ncbi.nlm.nih.gov/pubmed/15231574).

Citations:
[58](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15231574/citedby/) Fields:

Hem Hematology

Translation:HumansCellsCTClinical Trials

  154. [Berg SL](https://profiles.viictr.org/profile/266981), Aleksic A, McGuffey L, [Dauser R](https://profiles.viictr.org/profile/268165), [Nuchtern J](https://profiles.viictr.org/profile/266271), Bernacky B, **Blaney SM**. Plasma and cerebrospinal fluid pharmacokinetics of rebeccamycin (NSC 655649) in nonhuman primates. Cancer Chemother Pharmacol. 2004 Aug; 54(2):127-30. PMID: [15150671](//www.ncbi.nlm.nih.gov/pubmed/15150671).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15150671/citedby/) Fields:

Ant Antineoplastic AgentsNeo Neoplasms

Translation:Animals

  155. Aquino VM, Weitman SD, Winick NJ, **Blaney S** , Furman WL, Kepner JL, Bonate P, Krailo M, Qu W, Bernstein M. Phase I trial of tirapazamine and cyclophosphamide in children with refractory solid tumors: a pediatric oncology group study. J Clin Oncol. 2004 Apr 15; 22(8):1413-9. PMID: [15084615](//www.ncbi.nlm.nih.gov/pubmed/15084615).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15084615/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  156. Neville K, Parise RA, Thompson P, Aleksic A, Egorin MJ, Balis FM, McGuffey L, McCully C, [Berg SL](https://profiles.viictr.org/profile/266981), **Blaney SM**. Plasma and cerebrospinal fluid pharmacokinetics of imatinib after administration to nonhuman primates. Clin Cancer Res. 2004 Apr 01; 10(7):2525-9. PMID: [15073132](//www.ncbi.nlm.nih.gov/pubmed/15073132).

Citations:
[21](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15073132/citedby/) Fields:

Neo Neoplasms

Translation:AnimalsCells

  157. [Berg SL](https://profiles.viictr.org/profile/266981), Stone J, Xiao JJ, Chan KK, [Nuchtern J](https://profiles.viictr.org/profile/266271), [Dauser R](https://profiles.viictr.org/profile/268165), McGuffey L, Thompson P, **Blaney SM**. Plasma and cerebrospinal fluid pharmacokinetics of depsipeptide (FR901228) in nonhuman primates. Cancer Chemother Pharmacol. 2004 Jul; 54(1):85-8. PMID: [15042312](//www.ncbi.nlm.nih.gov/pubmed/15042312).

Citations:
[19](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15042312/citedby/) Fields:

Ant Antineoplastic AgentsNeo Neoplasms

Translation:Animals

  158. Adamson PC, **Blaney SM** , Widemann BC, Kitchen B, Murphy RF, Hannah AL, Cropp GF, Patel M, Gillespie AF, Whitcomb PG, Balis FM. Pediatric phase I trial and pharmacokinetic study of the platelet-derived growth factor (PDGF) receptor pathway inhibitor SU101. Cancer Chemother Pharmacol. 2004 Jun; 53(6):482-8. PMID: [14999430](//www.ncbi.nlm.nih.gov/pubmed/14999430).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14999430/citedby/) Fields:

Ant Antineoplastic AgentsNeo Neoplasms

Translation:HumansCTClinical Trials

  159. Thompson PA, [Berg SL](https://profiles.viictr.org/profile/266981), Aleksic A, Kerr JZ, McGuffey L, [Dauser R](https://profiles.viictr.org/profile/268165), [Nuchtern JG](https://profiles.viictr.org/profile/266271), Hausheer F, **Blaney SM**. Plasma and cerebrospinal fluid pharmacokinetic study of BNP1350 in nonhuman primates. Cancer Chemother Pharmacol. 2004 Jun; 53(6):527-32. PMID: [14997342](//www.ncbi.nlm.nih.gov/pubmed/14997342).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14997342/citedby/) Fields:

Ant Antineoplastic AgentsNeo Neoplasms

Translation:Animals

  160. Li XN, Parikh S, Shu Q, Jung HL, Chow CW, Perlaky L, Leung HC, [Su J](https://profiles.viictr.org/profile/268196), **Blaney S** , Lau CC. Phenylbutyrate and phenylacetate induce differentiation and inhibit proliferation of human medulloblastoma cells. Clin Cancer Res. 2004 Feb 01; 10(3):1150-9. PMID: [14871995](//www.ncbi.nlm.nih.gov/pubmed/14871995).

Citations:
[27](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14871995/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  161. Renbarger J, Aleksic A, McGuffey L, [Dauser R](https://profiles.viictr.org/profile/268165), [Berg S](https://profiles.viictr.org/profile/266981), **Blaney S**. Plasma and cerebrospinal fluid pharmacokinetics of SU5416 after intravenous administration in nonhuman primates. Cancer Chemother Pharmacol. 2004 Jan; 53(1):39-42. PMID: [14551735](//www.ncbi.nlm.nih.gov/pubmed/14551735).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14551735/citedby/) Fields:

Ant Antineoplastic AgentsNeo Neoplasms

Translation:Animals

  162. Thompson P, Balis F, Serabe BM, [Berg S](https://profiles.viictr.org/profile/266981), Adamson P, Klenke R, Aiken A, Packer R, Murry DJ, Jakacki R, **Blaney SM**. Pharmacokinetics of phenylacetate administered as a 30-min infusion in children with refractory cancer. Cancer Chemother Pharmacol. 2003 Nov; 52(5):417-23. PMID: [12879279](//www.ncbi.nlm.nih.gov/pubmed/12879279).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12879279/citedby/) Fields:

Ant Antineoplastic AgentsNeo Neoplasms

Translation:HumansCTClinical Trials

  163. Langevin AM, Weitman SD, Kuhn JG, Weintraub ST, Baruchel S, Furman W, Bernstein M, **Blaney S** , Vietti T, Pediatric Oncology Group Study. Phase I trial of rebeccamycin analog (NSC #655649) in children with refractory solid tumors: a pediatric oncology group study. J Pediatr Hematol Oncol. 2003 Jul; 25(7):526-33. PMID: [12847318](//www.ncbi.nlm.nih.gov/pubmed/12847318).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12847318/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCTClinical Trials

  164. Hayashi RJ, **Blaney S** , Sullivan J, Weitman S, Vietti T, Bernstein ML, Pediatric Oncology Group Study. Phase 1 study of Paclitaxel administered twice weekly to children with refractory solid tumors: a pediatric oncology group study. J Pediatr Hematol Oncol. 2003 Jul; 25(7):539-42. PMID: [12847320](//www.ncbi.nlm.nih.gov/pubmed/12847320).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12847320/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCTClinical Trials

  165. Souid AK, Dubowy RL, **Blaney SM** , Hershon L, Sullivan J, McLeod WD, Bernstein ML. Phase I clinical and pharmacologic study of weekly cisplatin and irinotecan combined with amifostine for refractory solid tumors. Clin Cancer Res. 2003 Feb; 9(2):703-10. PMID: [12576438](//www.ncbi.nlm.nih.gov/pubmed/12576438).

Citations:
[14](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12576438/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  166. **Blaney SM** , Heideman R, [Berg S](https://profiles.viictr.org/profile/266981), Adamson P, Gillespie A, Geyer JR, Packer R, Matthay K, Jaeckle K, Cole D, Kuttesch N, [Poplack DG](https://profiles.viictr.org/profile/268156), Balis FM. Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis. J Clin Oncol. 2003 Jan 01; 21(1):143-7. PMID: [12506183](//www.ncbi.nlm.nih.gov/pubmed/12506183).

Citations:
[23](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12506183/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  167. Houghton PJ, Adamson PC, **Blaney S** , Fine HA, Gorlick R, Haber M, Helman L, Hirschfeld S, Hollingshead MG, Israel MA, Lock RB, Maris JM, Merlino G, Patterson W, Reynolds CP, Shannon K, Yu A, Yu J, Smith MA. Testing of new agents in childhood cancer preclinical models: meeting summary. Clin Cancer Res. 2002 Dec; 8(12):3646-57. PMID: [12473573](//www.ncbi.nlm.nih.gov/pubmed/12473573).

Citations:
[19](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12473573/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimals

  168. McGuffey LH, McCully CL, Bernacky BJ, **Blaney SM**. Incorporation of an enrichment program into a study protocol involving long-term restraint in macaques. Lab Anim (NY). 2002 Nov; 31(10):37-9. PMID: [12404014](//www.ncbi.nlm.nih.gov/pubmed/12404014).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12404014/citedby/) Fields:

Lab Laboratory Animal Science

Translation:Animals

  169. Egorin MJ, Zuhowski EG, McCully CM, **Blaney SM** , Kerr JZ, [Berg SL](https://profiles.viictr.org/profile/266981), Balis FM. Pharmacokinetics of intrathecal gemcitabine in nonhuman primates. Clin Cancer Res. 2002 Jul; 8(7):2437-42. PMID: [12114450](//www.ncbi.nlm.nih.gov/pubmed/12114450).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12114450/citedby/) Fields:

Neo Neoplasms

Translation:Animals

  170. Packer RJ, Biegel JA, **Blaney S** , Finlay J, Geyer JR, Heideman R, Hilden J, Janss AJ, Kun L, Vezina G, Rorke LB, Smith M. Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop. J Pediatr Hematol Oncol. 2002 Jun-Jul; 24(5):337-42. PMID: [12142780](//www.ncbi.nlm.nih.gov/pubmed/12142780).

Citations:
[71](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12142780/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCells

  171. Marina NM, Cochrane D, Harney E, Zomorodi K, **Blaney S** , Winick N, Bernstein M, Link MP. Dose escalation and pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in children with solid tumors: a pediatric oncology group study. Clin Cancer Res. 2002 Feb; 8(2):413-8. PMID: [11839657](//www.ncbi.nlm.nih.gov/pubmed/11839657).

Citations:
[28](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11839657/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  172. Murry DJ, Cherrick I, Salama V, [Berg S](https://profiles.viictr.org/profile/266981), Bernstein M, Kuttesch N, **Blaney SM**. Influence of phenytoin on the disposition of irinotecan: a case report. J Pediatr Hematol Oncol. 2002 Feb; 24(2):130-3. PMID: [11990699](//www.ncbi.nlm.nih.gov/pubmed/11990699).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11990699/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:Humans

  173. Goldstein SL, Murry DJ, May S, Aleksic A, Sowinski KM, **Blaney S**. Meropenem pharmacokinetics in children and adolescents receiving hemodialysis. Pediatr Nephrol. 2001 Dec; 16(12):1015-8. PMID: [11793091](//www.ncbi.nlm.nih.gov/pubmed/11793091).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11793091/citedby/) Fields:

Nep NephrologyPed Pediatrics

Translation:Humans

  174. [Chintagumpala M](https://profiles.viictr.org/profile/268049), Berg S, **Blaney SM**. Treatment controversies in medulloblastoma. Curr Opin Oncol. 2001 May; 13(3):154-9. PMID: [11307057](//www.ncbi.nlm.nih.gov/pubmed/11307057).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11307057/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  175. Berg S, Serabe B, Aleksic A, [Bomgaars L](https://profiles.viictr.org/profile/266256), McGuffey L, Dauser R, Durfee J, [Nuchtern J](https://profiles.viictr.org/profile/266271), **Blaney S**. Pharmacokinetics and cerebrospinal fluid penetration of phenylacetate and phenylbutyrate in the nonhuman primate. Cancer Chemother Pharmacol. 2001 May; 47(5):385-90. PMID: [11391852](//www.ncbi.nlm.nih.gov/pubmed/11391852).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11391852/citedby/) Fields:

Ant Antineoplastic AgentsNeo Neoplasms

Translation:Animals

  176. Kerr JZ, Berg SL, Dauser R, [Nuchtern J](https://profiles.viictr.org/profile/266271), Egorin MJ, McGuffey L, Aleksic A, **Blaney S**. Plasma and cerebrospinal fluid pharmacokinetics of gemcitabine after intravenous administration in nonhuman primates. Cancer Chemother Pharmacol. 2001 May; 47(5):411-4. PMID: [11391856](//www.ncbi.nlm.nih.gov/pubmed/11391856).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11391856/citedby/) Fields:

Ant Antineoplastic AgentsNeo Neoplasms

Translation:Animals

  177. Kerr JZ, Berg S, **Blaney SM**. Intrathecal chemotherapy. Crit Rev Oncol Hematol. 2001 Mar; 37(3):227-36. PMID: [11248578](//www.ncbi.nlm.nih.gov/pubmed/11248578).

Citations:
[24](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11248578/citedby/) Fields:

Hem HematologyNeo Neoplasms

Translation:Humans

  178. Pui CH, Mahmoud HH, Wiley JM, Woods GM, Leverger G, Camitta B, Hastings C, **Blaney SM** , Relling MV, Reaman GH. Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients With leukemia or lymphoma. J Clin Oncol. 2001 Feb 01; 19(3):697-704. PMID: [11157020](//www.ncbi.nlm.nih.gov/pubmed/11157020).

Citations:
[61](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11157020/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  179. **Blaney S** , Berg SL, Pratt C, Weitman S, Sullivan J, Luchtman-Jones L, Bernstein M. A phase I study of irinotecan in pediatric patients: a pediatric oncology group study. Clin Cancer Res. 2001 Jan; 7(1):32-7. PMID: [11205914](//www.ncbi.nlm.nih.gov/pubmed/11205914).

Citations:
[31](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11205914/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  180. [Bomgaars L](https://profiles.viictr.org/profile/266256), Berg SL, **Blaney SM**. The development of camptothecin analogs in childhood cancers. Oncologist. 2001; 6(6):506-16. PMID: [11743213](//www.ncbi.nlm.nih.gov/pubmed/11743213).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11743213/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  181. Berg SL, **Blaney SM** , Sullivan J, Bernstein M, Dubowy R, Harris MB, Pediatric Oncology Group. Phase II trial of pyrazoloacridine in children with solid tumors: a Pediatric Oncology Group phase II study. J Pediatr Hematol Oncol. 2000 Nov-Dec; 22(6):506-9. PMID: [11132217](//www.ncbi.nlm.nih.gov/pubmed/11132217); PMCID: [PMC4008246](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4008246).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11132217/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCTClinical Trials

  182. [Nuchtern J](https://profiles.viictr.org/profile/266271), McGuffey L, Durfee J, [Dauser R](https://profiles.viictr.org/profile/268165), **Blaney SM**. Modified procedure for implantation of subcutaneous central venous access devices in macaques (Macaca mulatta). Comp Med. 2000 Oct; 50(5):486-9. PMID: [11099129](//www.ncbi.nlm.nih.gov/pubmed/11099129).

Citations:  Fields:

Lab Laboratory Animal ScienceMed Medicine (General)

Translation:Animals

  183. Murry DJ, **Blaney SM**. Clinical pharmacology of encapsulated sustained-release cytarabine. Ann Pharmacother. 2000 Oct; 34(10):1173-8. PMID: [11054987](//www.ncbi.nlm.nih.gov/pubmed/11054987).

Citations:
[28](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11054987/citedby/) Fields:

Dru Drug TherapyPha Pharmacology

Translation:HumansAnimals

  184. **Blaney SM** , [Poplack DG](https://profiles.viictr.org/profile/268156). Neoplastic meningitis: diagnosis and treatment considerations. Med Oncol. 2000 Aug; 17(3):151-62. PMID: [10962524](//www.ncbi.nlm.nih.gov/pubmed/10962524).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/10962524/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  185. Riva L, **Blaney SM** , [Dauser R](https://profiles.viictr.org/profile/268165), [Nuchtern JG](https://profiles.viictr.org/profile/266271), Durfee J, McGuffey L, Berg SL. Pharmacokinetics and cerebrospinal fluid penetration of CI-994 (N-acetyldinaline) in the nonhuman primate. Clin Cancer Res. 2000 Mar; 6(3):994-7. PMID: [10741726](//www.ncbi.nlm.nih.gov/pubmed/10741726).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/10741726/citedby/) Fields:

Neo Neoplasms

Translation:Animals

  186. Balis FM, **Blaney SM** , McCully CL, Bacher JD, Murphy RF, [Poplack DG](https://profiles.viictr.org/profile/268156). Methotrexate distribution within the subarachnoid space after intraventricular and intravenous administration. Cancer Chemother Pharmacol. 2000; 45(3):259-64. PMID: [10663645](//www.ncbi.nlm.nih.gov/pubmed/10663645).

Citations:
[16](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/10663645/citedby/) Fields:

Ant Antineoplastic AgentsNeo Neoplasms

Translation:Animals

  187. Bernstein ML, Baruchel S, Devine S, Markoglou N, Wainer IW, Williams M, **Blaney S** , Moghrabi A, Winick N, Vietti T. Phase I and pharmacokinetic study of CI-980 in recurrent pediatric solid tumor cases: a Pediatric Oncology Group study. J Pediatr Hematol Oncol. 1999 Nov-Dec; 21(6):494-500. PMID: [10598660](//www.ncbi.nlm.nih.gov/pubmed/10598660).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/10598660/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCTClinical Trials

  188. Kitchen BJ, Moser A, Lowe E, Balis FM, Widemann B, Anderson L, Strong J, **Blaney SM** , Berg SL, O'Brien M, Adamson PC. Thioguanine administered as a continuous intravenous infusion to pediatric patients is metabolized to the novel metabolite 8-hydroxy-thioguanine. J Pharmacol Exp Ther. 1999 Nov; 291(2):870-4. PMID: [10525111](//www.ncbi.nlm.nih.gov/pubmed/10525111).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/10525111/citedby/) Fields:

Dru Drug TherapyPha Pharmacology

Translation:HumansCTClinical Trials

  189. Seibel NL, **Blaney SM** , O'Brien M, Krailo M, Hutchinson R, Mosher RB, Balis FM, Reaman GH. Phase I trial of docetaxel with filgrastim support in pediatric patients with refractory solid tumors: a collaborative Pediatric Oncology Branch, National Cancer Institute and Children's Cancer Group trial. Clin Cancer Res. 1999 Apr; 5(4):733-7. PMID: [10213206](//www.ncbi.nlm.nih.gov/pubmed/10213206).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/10213206/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  190. Serabe BM, Murry DJ, [Dauser R](https://profiles.viictr.org/profile/268165), [Nuchtern J](https://profiles.viictr.org/profile/266271), Durfee J, McGuffey L, Berg S, **Blaney SM**. Plasma and CSF pharmacokinetics of ganciclovir in nonhuman primates. Cancer Chemother Pharmacol. 1999; 43(5):415-8. PMID: [10100598](//www.ncbi.nlm.nih.gov/pubmed/10100598).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/10100598/citedby/) Fields:

Ant Antineoplastic AgentsNeo Neoplasms

Translation:Animals

  191. Langevin AM, Casto DT, Thomas PJ, Weitman SD, Kretschmar C, Grier H, Pratt C, Dubowy R, Bernstein M, **Blaney S** , Vietti T. Phase I trial of 9-aminocamptothecin in children with refractory solid tumors: a Pediatric Oncology Group study. J Clin Oncol. 1998 Jul; 16(7):2494-9. PMID: [9667269](//www.ncbi.nlm.nih.gov/pubmed/9667269).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9667269/citedby/) Fields:

Neo Neoplasms

Translation:HumansPHPublic HealthCTClinical Trials

  192. **Blaney SM** , [Poplack DG](https://profiles.viictr.org/profile/268156). New cytotoxic drugs for intrathecal administration. J Neurooncol. 1998 Jun-Jul; 38(2-3):219-23. PMID: [9696375](//www.ncbi.nlm.nih.gov/pubmed/9696375).

Citations:
[13](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9696375/citedby/) Fields:

Neo NeoplasmsNeu Neurology

Translation:Humans

  193. Parikh SH, [Chintagumpala M](https://profiles.viictr.org/profile/268049), Hicks MJ, Trautwein LM, **Blaney S** , [Minifee P](https://profiles.viictr.org/profile/266524), Woo SY. Clear cell sarcoma of the kidney: an unusual presentation and review of the literature. J Pediatr Hematol Oncol. 1998 Mar-Apr; 20(2):165-8. PMID: [9544171](//www.ncbi.nlm.nih.gov/pubmed/9544171).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9544171/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:Humans

  194. **Blaney SM** , Needle MN, Gillespie A, Sato JK, Reaman GH, Berg SL, Adamson PC, Krailo MD, Bleyer WA, [Poplack DG](https://profiles.viictr.org/profile/268156), Balis FM. Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study. Clin Cancer Res. 1998 Feb; 4(2):357-60. PMID: [9516923](//www.ncbi.nlm.nih.gov/pubmed/9516923).

Citations:
[13](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9516923/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  195. Berg SL, **Blaney SM** , Adamson PC, O'Brien M, [Poplack DG](https://profiles.viictr.org/profile/268156), Arndt C, Blatt J, Balis FM. Phase I trial and pharmacokinetic study of pyrazoloacridine in children and young adults with refractory cancers. J Clin Oncol. 1998 Jan; 16(1):181-6. PMID: [9440741](//www.ncbi.nlm.nih.gov/pubmed/9440741).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9440741/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  196. **Blaney SM** , Takimoto C, Murry DJ, Kuttesch N, McCully C, Cole DE, Godwin K, Balis FM. Plasma and cerebrospinal fluid pharmacokinetics of 9-aminocamptothecin (9-AC), irinotecan (CPT-11), and SN-38 in nonhuman primates. Cancer Chemother Pharmacol. 1998; 41(6):464-8. PMID: [9554590](//www.ncbi.nlm.nih.gov/pubmed/9554590).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9554590/citedby/) Fields:

Ant Antineoplastic AgentsNeo Neoplasms

Translation:Animals

  197. Adamson PC, Reaman G, Finklestein JZ, Feusner J, Berg SL, **Blaney SM** , O'Brien M, Murphy RF, Balis FM. Phase I trial and pharmacokinetic study of all-trans-retinoic acid administered on an intermittent schedule in combination with interferon-alpha2a in pediatric patients with refractory cancer. J Clin Oncol. 1997 Nov; 15(11):3330-7. PMID: [9363862](//www.ncbi.nlm.nih.gov/pubmed/9363862).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9363862/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  198. **Blaney SM** , Seibel NL, O'Brien M, Reaman GH, Berg SL, Adamson PC, [Poplack DG](https://profiles.viictr.org/profile/268156), Krailo MD, Mosher R, Balis FM. Phase I trial of docetaxel administered as a 1-hour infusion in children with refractory solid tumors: a collaborative pediatric branch, National Cancer Institute and Children's Cancer Group trial. J Clin Oncol. 1997 Apr; 15(4):1538-43. PMID: [9193350](//www.ncbi.nlm.nih.gov/pubmed/9193350).

Citations:
[20](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9193350/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  199. **Blaney SM** , Phillips PC, Packer RJ, Heideman RL, Berg SL, Adamson PC, Allen JC, Sallan SE, Jakacki RI, Lange BJ, Reaman GH, Horowitz ME, [Poplack DG](https://profiles.viictr.org/profile/268156), Balis FM. Phase II evaluation of topotecan for pediatric central nervous system tumors. Cancer. 1996 Aug 01; 78(3):527-31. PMID: [8697400](//www.ncbi.nlm.nih.gov/pubmed/8697400).

Citations:
[21](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8697400/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  200. **Blaney SM** , [Poplack DG](https://profiles.viictr.org/profile/268156). Pharmacologic strategies for the treatment of meningeal malignancy. Invest New Drugs. 1996; 14(1):69-85. PMID: [8880395](//www.ncbi.nlm.nih.gov/pubmed/8880395).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8880395/citedby/) Fields:

Ant Antineoplastic AgentsPha Pharmacology

Translation:Humans

  201. **Blaney SM** , [Poplack DG](https://profiles.viictr.org/profile/268156). Central nervous system leukemia. Curr Opin Oncol. 1996 Jan; 8(1):13-9. PMID: [8868094](//www.ncbi.nlm.nih.gov/pubmed/8868094).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8868094/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  202. Ho PT, Zimmerman K, Wexler LH, **Blaney S** , Jarosinski P, Weaver-McClure L, Izraeli S, Balis FM. A prospective evaluation of ifosfamide-related nephrotoxicity in children and young adults. Cancer. 1995 Dec 15; 76(12):2557-64. PMID: [8625085](//www.ncbi.nlm.nih.gov/pubmed/8625085).

Citations:
[21](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8625085/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  203. **Blaney SM** , Daniel MJ, Harker AJ, Godwin K, Balis FM. Pharmacokinetics of lamivudine and BCH-189 in plasma and cerebrospinal fluid of nonhuman primates. Antimicrob Agents Chemother. 1995 Dec; 39(12):2779-82. PMID: [8593019](//www.ncbi.nlm.nih.gov/pubmed/8593019); PMCID: [PMC163029](//www.ncbi.nlm.nih.gov/pmc/articles/PMC163029).

Citations:
[21](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8593019/citedby/) Fields:

Ant Anti-Infective Agents

Translation:Animals

  204. Adamson PC, Balis FM, Belasco JE, Lange B, Berg SL, **Blaney SM** , Craig C, [Poplack DG](https://profiles.viictr.org/profile/268156). A phase I trial of amifostine (WR-2721) and melphalan in children with refractory cancer. Cancer Res. 1995 Sep 15; 55(18):4069-72. PMID: [7664282](//www.ncbi.nlm.nih.gov/pubmed/7664282).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/7664282/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  205. **Blaney SM** , [Poplack DG](https://profiles.viictr.org/profile/268156), Godwin K, McCully CL, Murphy R, Balis FM. Effect of body position on ventricular CSF methotrexate concentration following intralumbar administration. J Clin Oncol. 1995 Jan; 13(1):177-9. PMID: [7799017](//www.ncbi.nlm.nih.gov/pubmed/7799017).

Citations:
[18](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/7799017/citedby/) Fields:

Neo Neoplasms

Translation:Animals

  206. **Blaney SM** , Cole DE, Godwin K, Sung C, [Poplack DG](https://profiles.viictr.org/profile/268156), Balis FM. Intrathecal administration of topotecan in nonhuman primates. Cancer Chemother Pharmacol. 1995; 36(2):121-4. PMID: [7767947](//www.ncbi.nlm.nih.gov/pubmed/7767947).

Citations:
[18](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/7767947/citedby/) Fields:

Ant Antineoplastic AgentsNeo Neoplasms

Translation:Animals

  207. Sung C, **Blaney SM** , Cole DE, Balis FM, Dedrick RL. A pharmacokinetic model of topotecan clearance from plasma and cerebrospinal fluid. Cancer Res. 1994 Oct 01; 54(19):5118-22. PMID: [7923128](//www.ncbi.nlm.nih.gov/pubmed/7923128).

Citations:
[23](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/7923128/citedby/) Fields:

Neo Neoplasms

Translation:Animals

  208. Izraeli S, Adamson PC, **Blaney SM** , Balis FM. Acute pancreatitis after ifosfamide therapy. Cancer. 1994 Sep 01; 74(5):1627-8. PMID: [8062195](//www.ncbi.nlm.nih.gov/pubmed/8062195).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8062195/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  209. **Blaney SM** , Grem JL, Balis FM, Cole DE, Adamson PC, [Poplack DG](https://profiles.viictr.org/profile/268156). Mechanism of resistance to cyclopentenyl cytosine (CPE-C) in Molt-4 lymphoblasts. Biochem Pharmacol. 1993 Apr 06; 45(7):1493-501. PMID: [8471071](//www.ncbi.nlm.nih.gov/pubmed/8471071).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8471071/citedby/) Fields:

Bio BiochemistryPha Pharmacology

Translation:HumansCells

  210. **Blaney SM** , Balis FM, Cole DE, Craig C, Reid JM, Ames MM, Krailo M, Reaman G, Hammond D, [Poplack DG](https://profiles.viictr.org/profile/268156). Pediatric phase I trial and pharmacokinetic study of topotecan administered as a 24-hour continuous infusion. Cancer Res. 1993 Mar 01; 53(5):1032-6. PMID: [8439950](//www.ncbi.nlm.nih.gov/pubmed/8439950).

Citations:
[21](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8439950/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  211. **Blaney SM** , Cole DE, Balis FM, Godwin K, [Poplack DG](https://profiles.viictr.org/profile/268156). Plasma and cerebrospinal fluid pharmacokinetic study of topotecan in nonhuman primates. Cancer Res. 1993 Feb 15; 53(4):725-7. PMID: [8428353](//www.ncbi.nlm.nih.gov/pubmed/8428353).

Citations:
[24](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8428353/citedby/) Fields:

Neo Neoplasms

Translation:AnimalsCells

  212. **Blaney SM** , Smith MA, Grem JL. Doxorubicin: role in the treatment of osteosarcoma. Cancer Treat Res. 1993; 62:55-73. PMID: [8096760](//www.ncbi.nlm.nih.gov/pubmed/8096760).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8096760/citedby/) Fields:

Neo NeoplasmsThe Therapeutics

Translation:Humans

  213. **Blaney SM** , Balis FM, Grem J, Cole DE, Adamson PC, [Poplack DG](https://profiles.viictr.org/profile/268156). Modulation of the cytotoxic effect of cyclopentenylcytosine by its primary metabolite, cyclopentenyluridine. Cancer Res. 1992 Jun 15; 52(12):3503-5. PMID: [1596909](//www.ncbi.nlm.nih.gov/pubmed/1596909).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1596909/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  214. Balis FM, Pizzo PA, Butler KM, Hawkins ME, Brouwers P, Husson RN, Jacobsen F, **Blaney SM** , Gress J, Jarosinski P, et al. Clinical pharmacology of 2',3'-dideoxyinosine in human immunodeficiency virus-infected children. J Infect Dis. 1992 Jan; 165(1):99-104. PMID: [1727902](//www.ncbi.nlm.nih.gov/pubmed/1727902).

Citations:
[27](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1727902/citedby/) Fields:

Com Communicable Diseases

Translation:HumansCellsCTClinical Trials

  215. Balis FM, **Blaney SM** , [Poplack DG](https://profiles.viictr.org/profile/268156). Antiretroviral drug development and clinical pharmacology. Pediatr Infect Dis J. 1991 Nov; 10(11):849-57. PMID: [1661004](//www.ncbi.nlm.nih.gov/pubmed/1661004).

Citations:  Fields:

Com Communicable DiseasesPed Pediatrics

Translation:HumansAnimals

  216. **Blaney SM** , Balis FM, [Poplack DG](https://profiles.viictr.org/profile/268156). Pharmacologic approaches to the treatment of meningeal malignancy. Oncology (Williston Park). 1991 May; 5(5):107-16; discussion 123, 127. PMID: [1831994](//www.ncbi.nlm.nih.gov/pubmed/1831994).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1831994/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  217. **Blaney SM** , Balis FM, [Poplack DG](https://profiles.viictr.org/profile/268156). Current pharmacological treatment approaches to central nervous system leukaemia. Drugs. 1991 May; 41(5):702-16. PMID: [1712705](//www.ncbi.nlm.nih.gov/pubmed/1712705).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1712705/citedby/) Fields:

Dru Drug TherapyPha Pharmacology

Translation:HumansCTClinical Trials

  218. **Blaney SM** , Balis FM, Hegedus L, Heideman RL, McCully C, Murphy RF, Kelley JA, [Poplack DG](https://profiles.viictr.org/profile/268156). Pharmacokinetics and metabolism of cyclopentenyl cytosine in nonhuman primates. Cancer Res. 1990 Dec 15; 50(24):7915-9. PMID: [2253232](//www.ncbi.nlm.nih.gov/pubmed/2253232).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/2253232/citedby/) Fields:

Neo Neoplasms

Translation:AnimalsCells

This graph shows the total number of publications by year. To see the data as
text, click here.

![Bar chart showing 208 publications over 30 distinct years, with a maximum of
18 publications in
2010](//chart.googleapis.com/chart?chs=595x100&chf=bg,s,ffffff|c,s,ffffff&chxt=x,y&chxl=0:|'94||'96||'98||'00||'02||'04||'06||'08||'10||'12||'14||'16||'18||'20||'22||'24|1:|0|18&cht=bvs&chd=t:11,28,17,11,33,22,33,44,33,33,72,83,72,78,94,28,100,50,44,44,50,22,22,39,22,22,17,17,6,0,6&chdl=Publications&chco=80B1D3&chbh=10)

This graph shows the total number of publications by year. To return to the
graph, click here.

Year| Publications  
---|---  
1994| 2  
1995| 5  
1996| 3  
1997| 2  
1998| 6  
1999| 4  
2000| 6  
2001| 8  
2002| 6  
2003| 6  
2004| 13  
2005| 15  
2006| 13  
2007| 14  
2008| 17  
2009| 5  
2010| 18  
2011| 9  
2012| 8  
2013| 8  
2014| 9  
2015| 4  
2016| 4  
2017| 7  
2018| 4  
2019| 4  
2020| 3  
2021| 3  
2022| 1  
2024| 1  
  
This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

Start with: newest oldest Include: line numbers double spacing all authors
publication IDs

BLANEY's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (637)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

Derived automatically from this person's publications.

  * [Antineoplastic Agents](https://profiles.viictr.org/profile/252751)
  * [Brain Stem Neoplasms](https://profiles.viictr.org/profile/263388)
  * [Neoplasms](https://profiles.viictr.org/profile/260379)
  * [Camptothecin](https://profiles.viictr.org/profile/248532)
  * [Maximum Tolerated Dose](https://profiles.viictr.org/profile/249719)

[Explore](https://profiles.viictr.org/profile/268174/198)

_

Co-Authors (53)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People in Profiles who have published with this person.

  * [BERG, STACEY](https://profiles.viictr.org/profile/266981)
  * [BOMGAARS, LISA](https://profiles.viictr.org/profile/266256)
  * [POPLACK, DAVID](https://profiles.viictr.org/profile/268156)
  * [SU, JACK](https://profiles.viictr.org/profile/268196)
  * [SCHAFER, ERIC](https://profiles.viictr.org/profile/270055)

[Explore](https://profiles.viictr.org/profile/268174/345)

_

Similar People (60)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People who share similar concepts with this person.

  * [KANTARJIAN, HAGOP M](https://profiles.viictr.org/profile/12582901)
  * [CORTES, JORGE E](https://profiles.viictr.org/profile/12582539)
  * [JABBOUR, ELIAS JOSEPH](https://profiles.viictr.org/profile/12583425)
  * [BRUERA, EDUARDO](https://profiles.viictr.org/profile/12582968)
  * [GARCIA-MANERO, GUILLERMO](https://profiles.viictr.org/profile/12583738)

[Explore](https://profiles.viictr.org/profile/268174/476)

_

Same Department [ ![Expand
Description](https://profiles.viictr.org/Framework/Images/info.png)
](JavaScript:toggleVisibility\('sdDescript'\);)

People who are also in this person's primary department.

  * [BRENNER, MALCOLM](https://profiles.viictr.org/profile/268200)
  * [GRIM, AUSTYN](https://profiles.viictr.org/profile/30445276)
  * [PAEK, HANA](https://profiles.viictr.org/profile/30445271)
  * [SPREHE, MICHAEL](https://profiles.viictr.org/profile/7520379)
  * [TEO, WAN-YEE](https://profiles.viictr.org/profile/18830391)

[Explore](https://profiles.viictr.org/search/default.aspx?searchtype=people&searchfor=&SearchRequest=A81BSfTwU3GNm4liSODkW6vB3EBYO6gz+a5TY1bFhuz1tc7ngL4Orww3064KoquG+9VriFtrDjogfSknlN6Jz7ictMT0qk3g10zM0TMIEPsEyvmx6bLpcnNFGJ4exv4/fFAesBf4NHrkI4nVpsBeSKg1prKuDu5Ad3xZR2IG1VXzQt2Kl5Hs5a708T2/vlG+0DSye5g9KBjG4Q1kuBhnZAsDzRQkDR38klnZT2UlnG774nyA2dru0SIu9XaJe2Vd5sGS5MfW+ZRpNT79jDpQICGGFNfg5WTlXIPkbYJjpf3YGfCjPCJ3A81UJRyGY9MF14VFc7hjK08KUw/CXldSQkQX94mkjqn1GRbJZcV6q8YMdcbUB3UeVgUHmLQA7INKLsictgHvVcL1tc7ngL4Or2BgPoCYhvcEdI9fj5a9U4/8OigV51+oglRnSu//SLHvjH1HWb7OWmYrCEOhNlmBq7Z/PsLHWsJSZIAfV8346VMVWsQSiN3oIGGN9jLXSZC010kNGYH6yvTtuL5pI2IiiZgevCUih0f3vmYbjqDWiC08TnyRrJKGE/Ija0iyg/oaKwhDoTZZgau2fz7Cx1rCUmSAH1fN+OlTFVrEEojd6CBhjfYy10mQtNdJDRmB+sr0qj61OBf+xqDD+6Clu8wvckIBgwTrFvbm7X3tdBvSWESSFAIovZGCSzP0EoNHt5PiUF26eANDXMkWXAx5IRPustF+EEOAWlaZMfmQk2RtrZ8KVVPJ9ULGiQTN/PyW6vHZjcQbuuaMR4JpF2jOOFZEaWue6vkhtoRwwfdN4TTmOan9ztqBxhOvMb+us3lPmnf2tt1S1Z0IDTE7qPP/7M2jzFN6foNWCqqLRb/LXAdoFsRpMPt345sB8SI9K3ixiSN+kccJVanciBCNm4liSODkW2tuMX0EQMJeJ1NvmZC7MMfIH0G3DzFa7Ww3kCPpSspax47lNl+obrMAl6LnDsmqO6LI4XK0QanMi19EAkvoFc7JmZNEJTRG2uqY8pTR84tJVXfmR7Dk5CJCe/cQ6H6rtg==)

_

Physical Neighbors
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People whose addresses are nearby this person.

  * [BASINGER, SCOTT](https://profiles.viictr.org/profile/265874)
  * [BRENNER, MALCOLM](https://profiles.viictr.org/profile/268200)
  * [GOKULAKRISHNAN, GANGA](https://profiles.viictr.org/profile/265702)
  * [GOMBOS, DAN](https://profiles.viictr.org/profile/268390)
  * [TRAN, JOE](https://profiles.viictr.org/profile/266800)

_

